#news: Today at #ctad2026, we presented initial five-year follow-up data in early Alzheimer's disease, including clinical outcomes, disease progression, and safety. Read more: investors.biogen.com/news-releases/news-release-details/n…
Biogen
Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, United States specializing in the treatment of neurological diseases. The company's primary products are dimethyl fumarate (Tecfidera), diroximel fumarate (Vumerity), interferon beta-1a (AVONEX), peginterferon beta-1a (Plegridy), and natalizumab (Tysabri), all for the treatment of multiple sclerosis (collectively 45% of 2024 revenues); nusinersen (Spinraza) for the treatment of spinal muscular atrophy (16.2% of 2024 revenues); omaveloxolone (Skyclarys) for the treatment of Friedreich's ataxia (4.0% of 2024 revenues); tofersen (Qalsody) for the treatment of ALS; and dimethyl fumarate (Fumaderm) for the treatment of severe plaque psoriasis. The company also produces 5 biosimilars (8.2% of 2024 revenues) and has collaborations with Genentech for several drugs (18.1% of 2024 revenues). More on Wikipedia
-
Biogen
@biogen
-
Biogen
@biogen
#news: At the American College of Rheumatology (ACR) Convergence we announced data for an investigational therapy for people living with systemic lupus erythematosus (SLE). Read more: investors.biogen.com/news-releases/news-release-details/a…
-
Biogen
@biogen
We're heading to #bioeurope! Join our panel discussion to hear insights on advancing innovation, strategic partnerships, and the shifting global landscape. Learn about our partnering opportunities across the globe: www.biogen.com/partnering-intercontinental.html
-
Biogen
@biogen
#news: Massachusetts roots, global impact. We’re proud to be in our home state for #ctad2026, presenting new data from our Alzheimer’s disease portfolio. Read about our upcoming presentations: investors.biogen.com/news-releases/news-release-details/b…
-
Biogen
@biogen
STARTING SOON: Join our Q3 2026 financial results live webcast at 8:30AM ET. Join here: event.webcasts.com/starthere.jsp?ei=1771787&tp_key=52bcd1…
#earnings $BIIB -
Biogen
@biogen
#news: Today we reported our Q3 results, demonstrating that Biogen has returned to growth. Read more: investors.biogen.com/news-releases/news-release-details/b…
Forward-looking statements: www.biogen.com/forward-looking-statements.html
#earnings $BIIB -
Biogen
@biogen
At @ASNKidney #kidneywk we’re presenting the latest data across our kidney disease portfolio. Stop by booth #588 and join us at our medical symposiums to learn about our ongoing work to address the unmet needs of this community.
-
Biogen
@biogen
#news: We’re attending @ASNKidney #kidneywk to share data from our nephrology portfolio. Read more about our upcoming presentations: investors.biogen.com/news-releases/news-release-details/b…
-
Biogen
@biogen
#news: Biogen New Ventures is proud to participate in the Series A financing of Estuary Biotherapeutics, a company pioneering targeted gene therapies for autosomal dominant polycystic kidney disease (ADPKD). Learn more: estuarybio.com/news/estuary-series-a
-
Biogen
@biogen
#news: Biogen New Ventures is proud to participate in Altay Therapeutics' Series A financing to support the development of an investigational oral therapy for facioscapulohumeral muscular dystrophy (FSHD). Learn more: www.businesswire.com/news/home/20261014001074/en/Altay-Th…
-
Biogen
@biogen
#news: Today, we announced long-term 52-week results from a Phase 2 study in people living with cutaneous lupus erythematosus (CLE). Read more: investors.biogen.com/news-releases/news-release-details/b…
-
Biogen
@biogen
Find us at the #eadvcongress at booth #2212 to dive into our evolving research in CLE, a serious and chronic autoimmune skin disease that currently has no targeted therapies.
-
Biogen
@biogen
#news: Today, the Clinical Journal of the American Society of Nephrology published results from a Phase 3 analysis in adolescents with C3G and primary IC-MPGN. Read more: investors.biogen.com/news-releases/news-release-details/p…
-
Biogen
@biogen
We’re heading to New Orleans for #psychcongress2026! Together with Supernus Pharmaceuticals, we’ll share the latest real-world evidence in postpartum depression (PPD).
Attending? Connect with our team and visit us at booth 1041. Learn more: www.hmpglobalevents.com/psych-congress -
Biogen
@biogen
#news: With @StokeTx we’re presenting data on an investigational drug for Dravet syndrome at #eec2026. Read more about these data: investors.biogen.com/news-releases/news-release-details/s…
-
Biogen
@biogen
#news: We are attending #eec2026 alongside @StokeTx to share our latest findings in Dravet syndrome. Read more about our upcoming presentations: investors.biogen.com/news-releases/news-release-details/s…
-
Biogen
@biogen
#news: We announced the completion of the acquisition of RayThera Inc. This acquisition marks another step in growing Biogen’s immunology portfolio, adding multiple potential assets for immune-mediated diseases. Read more: investors.biogen.com/news-releases/news-release-details/b…
-
Biogen
@biogen
We’re attending #glomconhawaii to share more about our approach to C3G and primary IC-MPGN. Stop by booth #25 to learn how Biogen is working to transform care in complement-driven and immune-mediated kidney diseases.
-
Biogen
@biogen
STARTING SOON: Join our Q2 2026 earnings call webcast at 8:30AM ET here: event.webcasts.com/starthere.jsp?ei=1762548&tp_key=34ad1d…
#earnings $BIIB -
Biogen
@biogen
Today, we reported our Q2 results, demonstrating progress toward our goal of sustainable revenue growth. Read more: investors.biogen.com/news-releases/news-release-details/b…
Forward-looking statements: www.biogen.com/forward-looking-statements.html
#earnings $BIIB -
Biogen
@biogen
#news: Today @synapticure announced its new ataxia care program. We’re proud to help support important awareness efforts as a part of our commitment to the broader ataxia communities. Read more: www.prnewswire.com/news-releases/synapticure-launches-gro…
-
Biogen
@biogen
#news: Together with Eisai, we announced that the FDA has approved a new delivery option for people living with early Alzheimer’s disease. Learn more: investors.biogen.com/news-releases/news-release-details/f…
-
Biogen
@biogen
#news: We’re attending the @alzassociation’s International Conference (#aaic26) to share new data from our Alzheimer’s disease portfolio—including initial data from the Phase 2 study of our investigational tau-targeting therapy. Learn more: investors.biogen.com/news-releases/news-release-details/b…
-
Biogen
@biogen
We’re in San Diego this week at #bio2026 and look forward to connecting with biotech leaders from across the globe who share our ambition to deliver medicines to help transform patients’ lives. Learn about our partnering opportunities around the world: www.biogen.com/partner-with-biogen.html
-
Biogen
@biogen
At the @ATCMeeting, we're sharing new data on our investigational therapy designed to target CD-38 cells in antibody-mediated rejection. Join us to learn about our ongoing research in kidney transplantation and our late-stage clinical trials. Learn more: www.biogen.com/disease-areas/kidney-disease.html
-
Biogen
@biogen
#news: Today, we announced an agreement to acquire RayThera Inc. With this deal, we aim to add multiple immunology assets to our portfolio that will contribute to our long-term pipeline potential. Read more about this deal: investors.biogen.com/news-releases/news-release-details/b…
-
Biogen
@biogen
#news: Today, we announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for an investigational therapy for spinal muscular atrophy (SMA). Learn more about this important milestone: investors.biogen.com/news-releases/news-release-details/b…
-
Biogen
@biogen
#news: With @ucb_news, we announced data at the European Alliance of Associations for Rheumatology (EULAR) 2026 Congress, for an investigational therapy for systemic lupus erythematosus (SLE). Learn more about the data: investors.biogen.com/news-releases/news-release-details/e…
-
Biogen
@biogen
#news: Today we announced we’re sharing 14 abstracts highlighting data from our nephrology portfolio at the European Renal Association (ERA) and American Transplant Congresses (ATC). Read more about our upcoming kidney presentations: investors.biogen.com/news-releases/news-release-details/b…
-
Biogen
@biogen
We’re attending the @ERAkidney Congress to share data on our investigational therapy targeting CD-38 cells in immune-mediated diseases. Join us to learn about our ongoing research and late-stage pipeline: www.biogen.com/disease-areas/kidney-disease.html
-
Biogen
@biogen
We’re joining the global rheumatology community at @eular_org to share our latest research focused on systemic lupus erythematosus (SLE). Find us at #eular2026 and learn more about our work in lupus: www.biogen.com/disease-areas/lupus.html
-
Biogen
@biogen
#news: With @ucb_news, we’re pleased to share that @TheLancet has published full results from a positive Phase 3 study for an investigational treatment for systemic lupus erythematosus (SLE). Read more: investors.biogen.com/news-releases/news-release-details/u…
-
Biogen
@biogen
#news: We announced topline results from a Phase 2 study for an investigational drug targeting tau in individuals with early Alzheimer’s disease. These results represent an important milestone for the field. Learn more: investors.biogen.com/news-releases/news-release-details/t…
-
Biogen
@biogen
#news: Today, we announced the successful completion of the acquisition of Apellis Pharmaceuticals. Learn more about this news: investors.biogen.com/news-releases/news-release-details/b…
-
Biogen
@biogen
STARTING SOON: Join our Q1 2026 financial results live webcast at 8AM ET. Join here: investors.biogen.com/events/event-details/q1-2026-earning…
#earnings $BIIB -
Biogen
@biogen
Today, we reported our Q1 results which reflect our meaningful progress advancing the New Biogen, focused on strong commercial and pipeline execution. Read more: investors.biogen.com/news-releases/news-release-details/b…
Forward-looking statements: www.biogen.com/forward-looking-statements.html
#earnings $BIIB -
Biogen
@biogen
Meet us at the #chinabiopartnering Forum April 28-29 and join our sessions to learn about Biogen’s focus on partnering for global impact and our commitment to innovation from China.
Discover our partnering opportunities across the globe: www.biogen.com/partnering-intercontinental.html -
Biogen
@biogen
#news: We announced an agreement with TJ Biopharma to acquire exclusive rights to an investigational treatment for immune-mediated diseases in the Greater China Region. With this, we will now own exclusive worldwide rights to this CD-38 directed antibody. investors.biogen.com/news-releases/news-release-details/b…
-
Biogen
@biogen
#news: We announced that we have entered into a definitive agreement to acquire @ApellisPharma. This potential acquisition will bring two best-in-class commercialized immunology medicines to Biogen and accelerate our entry into nephrology. Read more: investors.biogen.com/news-releases/news-release-details/b…
-
Biogen
@biogen
#news: Today, the FDA approved a new dosing regimen option for our spinal muscular atrophy (SMA) therapy. This approval represents an important step toward expanding options for people living with SMA. Learn more: investors.biogen.com/news-releases/news-release-details/f…
-
Biogen
@biogen
#news: At #aad2026, we’re presenting new data for an investigational medicine for cutaneous lupus erythematosus (CLE), highlighting our ongoing efforts to advance a potential new option for people living with this serious form of lupus.
Read more: investors.biogen.com/news-releases/news-release-details/b… -
Biogen
@biogen
#news: Together with Eisai, we’re sharing new real-world data at #adpd2026 evaluating long-term treatment persistence in the U.S. among people living with early Alzheimer’s disease. Read more: investors.biogen.com/news-releases/news-release-details/r…
-
Biogen
@biogen
#news: Join us at the American Academy of Dermatology (AAD) Annual Meeting to learn about our late-breaking research for a potential cutaneous lupus erythematosus (CLE) treatment. Read more about the data we’re sharing at #aad2026: investors.biogen.com/news-releases/news-release-details/b…
-
Biogen
@biogen
We’re heading to #adpd2026 to discuss the latest research, clinical trials, and treatments for Alzheimer's disease (AD) and Parkinson's disease. Find us at Booth #2 to learn how we’re advancing research in this space. Learn more: www.biogen.com/disease-areas/alzheimers-disease.html
-
Biogen
@biogen
#news: At the 2026 #mdaconference, hosted by @MDAorg, we’re presenting new Phase 1b results and details on the Phase 3 clinical development program for an investigational spinal muscular atrophy (SMA) medicine. Read more: investors.biogen.com/news-releases/news-release-details/b…
Biogen
@biogen
Video description: Animated clip reading SMA News: Data and updates on an investigational treatment for SMA
-
Biogen
@biogen
#news: We’re presenting new data and updates at the 2026 #mdaconference, hosted by @MDAorg, and #smaeurope. Learn about the latest updates from our spinal muscular atrophy (SMA) pipeline: investors.biogen.com/news-releases/news-release-details/b…
-
Biogen
@biogen
We look forward to sharing the latest progress in our ongoing systemic lupus erythematosus (SLE) research at #elm2026 this week, hosted by @SLEuroSociety, alongside other industry experts, clinicians and researchers.
Learn more about the event: www.sleuromeeting.eu -
Biogen
@biogen
STARTING SOON: Join our Q4 and full year 2025 financial results live webcast at 8:30 AM ET. Join here: event.webcasts.com/starthere.jsp?ei=1742560&tp_key=4fee97…
#earnings $BIIB -
Biogen
@biogen
Today, we reported our Q4 and full year 2025 financial results which reflect our continued focus on strong execution and financial discipline. Read more: investors.biogen.com/news-releases/news-release-details/b…
Forward-looking statements: www.biogen.com/forward-looking-statements.html
#earnings $BIIB -
Biogen
@biogen
#news: Data from a Phase 2/3 study for SMA has been published in @NatureMedicine, exploring the potential benefit for a broad range of people living with the disease.
Read more: investors.biogen.com/news-releases/news-release-details/n… -
Biogen
@biogen
#news: The FDA granted Breakthrough Therapy Designation for an investigational medicine for cutaneous lupus erythematosus (CLE), marking a step forward in advancing a potential new option for people living with CLE. Read more: investors.biogen.com/news-releases/news-release-details/b…
-
Biogen
@biogen
#news: Today, the European Commission (EC) approved a new dosing option for people living with spinal muscular atrophy (SMA). Read more: investors.biogen.com/news-releases/news-release-details/b…
-
Biogen
@biogen
We’re at #jpm26 highlighting our growth strategy, the foundation of the new Biogen, and the potential of our growing pipeline. Hear more from our CEO and join the webcast live on January 12 at 1:30pm PT/4:30pm ET. Register here: investors.biogen.com/events/event-details/biogen-present-…
-
Biogen
@biogen
#news: Final data from the Phase 3 study of amyotrophic lateral sclerosis (ALS) therapy has been published in @JAMANeuro.
Read more: investors.biogen.com/news-releases/news-release-details/j… -
Biogen
@biogen
With @StokeTx, we’re sharing new data on an investigational therapy for Dravet syndrome at the American Epilepsy Society (AES) Annual Meeting. Join us at #aes2025 and check out details about our presentations here: investors.biogen.com/news-releases/news-release-details/b…
-
Biogen
@biogen
#news: With @StokeTx, we’re attending the American Epilepsy Society (AES) to share new findings in Dravet syndrome. Learn more about our presentations at #aes2025: investors.biogen.com/news-releases/news-release-details/b…
-
Biogen
@biogen
#news: With Eisai, we completed a rolling submission for a Supplemental Biologics License Application (sBLA) aimed to expand options for how treatment may be administered as a starting dose for people living with early Alzheimer’s disease. Read on: investors.biogen.com/news-releases/news-release-details/e…
-
Biogen
@biogen
#news: We announced a multi-target research collaboration with Dayra Therapeutics for priority targets in immunological conditions. Read more: investors.biogen.com/news-releases/news-release-details/b…
-
Biogen
@biogen
#news: We're heading to #ctad2025 in San Diego! Discover our latest advancements in Alzheimer's disease research as we enhance our scientific understanding of disease progression, driving innovation and progress in treatment. See more: investors.biogen.com/news-releases/news-release-details/b…
-
Biogen
@biogen
#news: With @StokeTx, we announced the publication of two-year natural history data in @GreenJournal, the medical journal of the American Academy of Neurology. Learn more: investors.biogen.com/news-releases/news-release-details/b…
-
Biogen
@biogen
#news: Today, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for a new dosing option for people living with spinal muscular atrophy (SMA). Read more: investors.biogen.com/news-releases/news-release-details/h…
-
Biogen
@biogen
#news: We are excited to announce that we have completed the acquisition of Alcyone Therapeutics. Learn more about this announcement: investors.biogen.com/news-releases/news-release-details/b…
-
Biogen
@biogen
Join us at @ASNKidney #kidneywk to learn about our ongoing research in kidney disease and our late-stage clinical trials. Find us at booth #510!
-
Biogen
@biogen
#news: We’re presenting new data on an investigational treatment for immunoglobulin A nephropathy (IgAN) at @ASNKidney #kidneywk 2025. Learn more: investors.biogen.com/news-releases/news-release-details/b…
-
Biogen
@biogen
STARTING SOON: Join our Q3 2025 financial results live webcast at 8:30 AM ET to hear from our CEO and executive team on this quarter’s strong performance. Join here: investors.biogen.com/events/event-details/q3-2025-earning…
#earnings $BIIB -
Biogen
@biogen
Today, we reported our Q3 2025 financial results which reflect strong execution against our strategy. Read more: investors.biogen.com/news-releases/news-release-details/b…
Forward-looking statements: www.biogen.com/forward-looking-statements.html
#earnings $BIIB -
Biogen
@biogen
We’re in Chicago for #acr25 where we’ll share how we’re working to advance options for those living with lupus. Find us at booth #451 and visit our website to learn more about our work: www.biogen.com/disease-areas/lupus.html
-
Biogen
@biogen
#news: With @VanquaBio, we announced a license agreement that expands our early-stage immunology pipeline. Learn more: investors.biogen.com/news-releases/news-release-details/b…
-
Biogen
@biogen
#news: We’re presenting data from late-stage lupus research at #acr25 this week. Read more about our work to help improve outcomes for those living with this chronic disease: investors.biogen.com/news-releases/news-release-details/b…
-
Biogen
@biogen
#news: With Eisai, our treatment that offers at-home injections to help patients continue care has been named by @TIME as one of the “Best Inventions of 2025” in the Medical and Healthcare category. Read more: investors.biogen.com/news-releases/news-release-details/l…
-
Biogen
@biogen
#news: With @StokeTx, we presented data on an investigational treatment for Dravet syndrome at the 54th Child Neurology Society (CNS) Annual Meeting. Learn more: investors.biogen.com/news-releases/news-release-details/b…
-
Biogen
@biogen
#news: We announced plans to acquire @AlcyoneTx. With this acquisition, we’ll drive the development & commercialization of an investigational implantable intrathecal device for the delivery of antisense oligonucleotides (ASOs). investors.biogen.com/news-releases/news-release-details/b…
-
Biogen
@biogen
#news: The European Commission approved the first treatment for postpartum depression (PPD) in Europe. This approval is a significant step forward for maternal health and women across Europe. Read more about this news: investors.biogen.com/news-releases/news-release-details/b…
-
Biogen
@biogen
IgA Nephropathy (IgAN) is the most prevalent form of kidney disease. This week, we’re attending @iigann2025 to share the progress we’re making in advancing options for people living with IgAN. Learn more: www.biogen.com/disease-areas/kidney-disease.html?accKey=1
-
Biogen
@biogen
#news: We’re hosting a virtual investor seminar focused on the potential of our late-stage lupus portfolio. Join us at 10 a.m. ET to learn more: investors.biogen.com/news-releases/news-release-details/b…
-
Biogen
@biogen
#news: Together with Eisai, we announced the initiation of a rolling submission to the FDA seeking to expand how treatment may be administered as a starting dose for people living with early Alzheimer’s disease. Read more here: investors.biogen.com/news-releases/news-release-details/e…
-
Biogen
@biogen
#news: Today, with @StokeTx, we announced new data from studies of our investigational medicine for Dravet syndrome at #iec2025. Read more here: investors.biogen.com/news-releases/news-release-details/b…
-
Biogen
@biogen
#news: Today, together with Eisai, we announced that the FDA has approved a new dosing option for people living with early Alzheimer’s disease. Learn more: investors.biogen.com/news-releases/news-release-details/f…
-
Biogen
@biogen
#news: Today, with @StokeTx, we announced the planned presentations of new data from studies of our investigational medicine for Dravet syndrome at #iec2025. Read more: investors.biogen.com/news-releases/news-release-details/b…
-
Biogen
@biogen
#news: Together with @StokeTx, we announced the first patient has been dosed in a Phase 3 study for our investigational therapy for Dravet syndrome. Read more: investors.biogen.com/news-releases/news-release-details/b…
-
Biogen
@biogen
We’re heading to the World Transplant Congress 2025 to share how we're helping to advance research for people living with a kidney transplant. Find us at booth #912 and visit our website to learn more about our work: www.biogen.com/disease-areas/kidney-disease.html
-
Biogen
@biogen
STARTING SOON: Join our Q2 2025 financial results live webcast at 8:30 AM ET. Join here: event.webcasts.com/starthere.jsp?ei=1719561&tp_key=2a9671…
#earnings $BIIB -
Biogen
@biogen
#news: Read our Q2 2025 financial results here: investors.biogen.com/news-releases/news-release-details/b…
#earnings | $BIIB -
Biogen
@biogen
#news: At #aaic25, with Eisai we presented interim real-world data from two years of U.S. clinical experience with treatment in early Alzheimer’s disease. Learn more about this news: investors.biogen.com/news-releases/news-release-details/t…
-
Biogen
@biogen
#news: With Eisai, we presented two new data presentations at #aaic25 for treatment in early Alzheimer’s disease (AD). These studies are a step forward for the AD community and in advancing care options for people living with AD. Read more: investors.biogen.com/news/news-releases
-
Biogen
@biogen
#news: Today, we received a positive opinion from the European Medicine Agency’s Committee for Medicinal Products for Human Use (#chmp) for our postpartum depression (#ppd) treatment. Read the news here: investors.biogen.com/news-releases/news-release-details/z…
-
Biogen
@biogen
#news: We're thrilled to attend the Alzheimer's Association International Conference (#aaic) 2025 to share updates from our Alzheimer's disease portfolio. Read more here: investors.biogen.com/news-releases/news-release-details/b…
-
Biogen
@biogen
#news: Today, we announced plans to invest $2 billion in our existing manufacturing footprint in North Carolina’s Research Triangle Park site to support our late-stage pipeline. Learn more about this news here: investors.biogen.com/news-releases/news-release-details/b…
-
Biogen
@biogen
#news: With @StokeTx, we announced new data from studies for an investigational medicine for Dravet Syndrome. Data were presented at the 16th European Paediatric Neurology Society Congress. Read the news here: investors.biogen.com/news-releases/news-release-details/b…
-
Biogen
@biogen
Biogen will report Q2 2025 financial results on July 31st before markets open in the U.S. Learn more: investors.biogen.com/news-releases/news-release-details/b…
#earnings $BIIB -
Biogen
@biogen
#news: Exciting progress is underway as we begin the Phase 3 study of our investigational therapy for kidney disease in adults with primary membranous nephropathy (PMN). Learn more: investors.biogen.com/news-releases/news-release-details/b…
-
Biogen
@biogen
#news: We’re committed to driving innovation to help redefine what’s possible for the care of spinal muscular atrophy (SMA).
We’re excited to share results from our ongoing research at the @CureSMA annual conference. Learn more about our findings: investors.biogen.com/news-releases/news-release-details/n… -
Biogen
@biogen
#news: Our latest data from a phase 1 study evaluates our novel investigational SMA therapy and supports our efforts to address the needs of SMA patients. Read more about our research presented at the @CureSMA conference: investors.biogen.com/news-releases/news-release-details/b…
-
Biogen
@biogen
#news: We announced the initiation of the Phase 3 Pediatric Study of an investigational form of medicine for Friedreich ataxia (FA). Learn about this news: investors.biogen.com/news-releases/news-release-details/b…
-
Biogen
@biogen
Our CEO and leadership team shared key insights about our rare kidney disease program. As we continue to advance research, our goal is to bring additional care options to patient populations living with kidney disease. Listen now: investors.biogen.com/events/event-details/biogen-investor…
-
Biogen
@biogen
#news: Along with @ucb_news, we are pleased to share data from our phase 3 clinical trial evaluating our investigational lupus therapy at #eular2025. Read more: investors.biogen.com/news-releases/news-release-details/d…
-
Biogen
@biogen
#news: Today we’re hosting a virtual investor seminar to highlight the potential of our investigational therapy for a range of immune-mediated diseases, including three Phase 3 programs in rare kidney diseases. Learn more and join us at 10 a.m. ET: investors.biogen.com/news-releases/news-release-details/b…
-
Biogen
@biogen
We’re heading to #eular2025 where we’ll share the latest updates from our ongoing lupus research!
We are excited to connect with rheumatologists & researchers to discuss the future of treatment. See how we’re addressing challenges: www.biogen.com/stories/lupus-innovation.html
Biogen
@biogen
Video description: Barcelona skyline with blue overlay. We look forward to sharing updates from our ongoing lupus research at EULAR 2025.
-
Biogen
@biogen
Building on the success of our existing programs, we’re continuing to advance R&D efforts to help make an impact for patients. Learn about the developments in our rare disease pipeline with insights from Biogen's CEO and leadership team. Register today: event.webcasts.com/starthere.jsp?ei=1719098&tp_key=9117a2…
-
Biogen
@biogen
#news: With @CityTx_ we announced a new research collaboration to develop select novel RNAi-based therapies. Learn more about this announcement: investors.biogen.com/news-releases/news-release-details/b…
-
Biogen
@biogen
Collaboration with other industry experts at events like @LupusCongress provides us with valuable insights to help drive progress for people living with lupus.
We look forward to attending #lupus2025.
Learn about our work: www.biogen.com/disease-areas/lupus.html -
Biogen
@biogen
We’re transforming what’s possible in neurology, immunology, and rare diseases by following promising science and establishing strategic partnerships. See how we’re making important progress in our pipeline to help advance health outcomes.
-
Biogen
@biogen
Our Q1 financial results support our strategy for long-term growth. We aim to bring innovative medicines to patients while generating value for our shareholders. Read more: event.webcasts.com/starthere.jsp?ei=1709792&tp_key=a6d681…
-
Biogen
@biogen
STARTING SOON: Join our Q1 2025 financial results live webcast at 8:30 AM ET. Join here: event.webcasts.com/starthere.jsp?ei=1709792&tp_key=a6d681…
#earnings $BIIB -
Biogen
@biogen
#news: Read our Q1 2025 financial results here: investors.biogen.com/news-releases/news-release-details/b…
#earnings | $BIIB -
Biogen
@biogen
#news: Our treatment for early #alzheimersdisease with Eisai has received EU approval, advancing care options across Europe. Learn more about this milestone and what it may mean for the future of Alzheimer’s care: investors.biogen.com/news-releases/news-release-details/l…
-
Biogen
@biogen
#news: Today we announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to one of our investigational drugs for Alzheimer's disease. Learn about this important news: investors.biogen.com/news-releases/news-release-details/b…
-
Biogen
@biogen
At #adpd2025, we’ll be discussing the role of tau in Alzheimer’s disease, including its link to disease progression and neuronal loss. Learn more about tau’s impact and explore interactive resources at knowtau.com.
-
Biogen
@biogen
We announced plans for a new global headquarters to open in Kendall Square in 2028 — marking Biogen's 50th anniversary. When open, this state-of-the-art facility will bring our Cambridge teams together at the heart of innovation and biotech.
-
Biogen
@biogen
#news: We announced the initiation of the Phase 3 study of our investigational therapy for late antibody-mediated rejection (AMR) in kidney transplant patients. Learn more about the news: investors.biogen.com/news-releases/news-release-details/b…
-
Biogen
@biogen
#news: We are excited to announce a new collaboration with Stoke Therapeutics for a potential first-in-class disease modifying medicine in development for the treatment of Dravet syndrome. Read the news: investors.biogen.com/news-releases/news-release-details/b…
-
Biogen
@biogen
This morning, we reported our Q4 and full year 2024 financial results. Watch the full recording here: event.webcasts.com/starthere.jsp?ei=1696634&tp_key=d47ceb…
#earnings $BIIB -
Biogen
@biogen
STARTING SOON: Join our Q4 and full year 2024 financial results live webcast at 8:30 AM ET. Join here: event.webcasts.com/starthere.jsp?ei=1696634&tp_key=d47ceb…
#earnings $BIIB -
Biogen
@biogen
#news: With Eisai, the U.S. Food and Drug Administration has approved a maintenance dose for people living with #alzheimersdisease. Learn more about this milestone: investors.biogen.com/news-releases/news-release-details/f…
-
Biogen
@biogen
#news: The U.S. Food and Drug Administration and the European Medicines Agency have accepted our marketing applications for an investigational form of a spinal muscular atrophy therapy. Learn more: investors.biogen.com/news-releases/news-release-details/f…
-
Biogen
@biogen
Biogen will report Q4 and full year 2024 financial results on February 12 before markets open in the U.S. Learn more: investors.biogen.com/news-releases/news-release-details/b…
#earnings $BIIB -
Biogen
@biogen
#news: With Eisai, we announced the completion of the filing submission with the U.S. Food and Drug Administration for our Alzheimer’s treatment. Learn more about this milestone: investors.biogen.com/news-releases/news-release-details/f…
-
Biogen
@biogen
Our CEO, Chris Viehbacher, is sharing Biogen’s strategy and key growth drivers at the 43rd Annual J.P. Morgan Healthcare Conference. Join the webcast live on January 14, at 9:45am PT/12:45pm ET. Register here: investors.biogen.com/events/event-details/biogen-jp-morga…
-
Biogen
@biogen
We’re attending the @jpmorgan Healthcare Conference. Ahead of #jpm25, our leaders are sharing how we're accelerating innovation to tackle some of the greatest unmet needs for patients. Learn about our research: www.biogen.com/science-and-innovation.html
-
Biogen
@biogen
#news: At #acr24, with @ucb_news, we shared detailed results from a Phase 3 study of our investigational therapy for moderate-to-severe systemic lupus erythematosus (SLE). Read more: investors.biogen.com/news-releases/news-release-details/d…
-
Biogen
@biogen
#news: With Eisai, we received a positive opinion from the Committee for Medicinal Products for Human Use, part of the European Medicines Agency. This represents a significant advancement in our commitment to people living with Alzheimer’s disease. investors.biogen.com/news-releases/news-release-details/e…
-
Biogen
@biogen
This morning, we reported our Q3 financial results. Learn more here: event.webcasts.com/starthere.jsp?ei=1681331&tp_key=17a234…
#earnings $BIIB -
Biogen
@biogen
STARTING SOON: Join our Q3 2024 financial results live webcast at 8:30 AM ET. Join here: event.webcasts.com/starthere.jsp?ei=1681331&tp_key=17a234…
#earnings $BIIB -
Biogen
@biogen
#news: Biogen will report Q3 2024 financial results today before markets open in the U.S.: investors.biogen.com/news-releases/news-release-details/b…
#earnings $BIIB -
Biogen
@biogen
#news: We announced a new multi-target research collaboration with Neomorph to discover & develop molecular glue degraders for priority targets in Alzheimer’s, rare, and immunological diseases. Read the news: investors.biogen.com/news-releases/news-release-details/b…
-
Biogen
@biogen
We’re presenting the latest data from our #alzheimersdisease (AD) portfolio at #ctad24! New research is vital for enhancing our understanding of AD and the role #tau plays in the disease. Visit knowtau.com to enrich your knowledge and learn more.
-
Biogen
@biogen
#news: We announced positive Phase 2 results for our investigational treatment for people living with IgA nephropathy at #kidneywk. Read on: investors.biogen.com/news-releases/news-release-details/b…
-
Biogen
@biogen
#news: We’re presenting new data from our #alzheimersdisease research portfolio at the upcoming Clinical Trials on Alzheimer’s Disease (#ctad24) annual conference in Madrid, Spain. Learn more: investors.biogen.com/news-releases/news-release-details/b…
-
Biogen
@biogen
#news: We’re presenting late breaker and new investigational data at @ASNKidney Week in San Diego. Learn More: investors.biogen.com/news-releases/news-release-details/b…
-
Biogen
@biogen
We’re seeking applications from innovators in #neuroscience and #biotech for the chance to receive a $50K credit for space at @LabCentral in Cambridge. Learn more and apply by November 15th: www.biogen.com/lab-central.html
-
Biogen
@biogen
#news: We’re partnering with @Talkiatry to improve access to #postpartumdepression (PPD) care for women, virtually. This new dedicated webpage may help increase access to #mentalhealth care services from their own home. Learn more: www.prnewswire.com/news-releases/talkiatry-expands-postpa…
-
Biogen
@biogen
#news: We are presenting detailed data for an investigational form of our spinal muscular atrophy (#sma) therapy at #wms2024.
Read more: investors.biogen.com/news-releases/news-release-details/n… -
Biogen
@biogen
We’re seeking applications from innovators in #neuroscience and #biotech for the chance to receive a $50K credit for space at @LabCentral in Cambridge. Learn more and apply by October 11th: www.biogen.com/lab-central.html
-
Biogen
@biogen
#news: Today, with @ucb_news, we shared positive topline results from a Phase 3 study of our investigational therapy for moderately to severely active systemic lupus erythematosus (SLE) and plans to start a second Phase 3 study. Read more: investors.biogen.com/news-releases/news-release-details/u…
-
Biogen
@biogen
#news: With Samsung Bioepis, our proposed #ophthalmology #biosimilar received a positive #chmp opinion from the European Medicines Agency. This marks a significant step forward in providing more affordable treatment options for patients. Read the news: investors.biogen.com/news-releases/news-release-details/s…
-
Biogen
@biogen
#news: We’ve announced new positive topline data for an investigational form of our spinal muscular atrophy (#sma) therapy, reinforcing our commitment to help improve outcomes for people living with this severe, lifelong disease. Read more: investors.biogen.com/news-releases/news-release-details/b…
-
Biogen
@biogen
We’re pleased to share that the Medicines and Healthcare products Regulatory Agency (MHRA) in the United Kingdom has approved our disease modifying therapy for #alzheimersdisease. Read more about this #news: investors.biogen.com/news-releases/news-release-details/l…
-
Biogen
@biogen
This morning, we reported our Q2 financial results. Learn more here: event.webcasts.com/starthere.jsp?ei=1678237&tp_key=77c50e…
#earnings $BIIB -
Biogen
@biogen
STARTING SOON: Join our Q2 2024 financial results live webcast at 8:30 AM ET. Join here: event.webcasts.com/starthere.jsp?ei=1678237&tp_key=77c50e…
#earnings $BIIB -
Biogen
@biogen
#news: With @BeckmanDx @FujirebioUS, we aim to identify and develop blood-based biomarkers and clinically advance new tests for tau pathology in Alzheimer’s disease that could be applied to clinical trials or enable adoption of future therapies. Read here: investors.biogen.com/news-releases/news-release-details/b…
-
Biogen
@biogen
We’re attending the Alzheimer’s Association International Conference (#aaic24) this weekend! Join us to see the latest data across our portfolio on #alzheimersdisease, a devastating disease impacting millions worldwide. Learn more about our research: www.biogen.com/disease-areas/alzheimers-disease.html
-
Biogen
@biogen
Biogen will report Q2 2024 financial results on August 1 before markets open in the U.S.: investors.biogen.com/news-releases/news-release-details/b…
#earnings $BIIB -
Biogen
@biogen
Biogen is excited to announce that the European Commission (EC) has granted marketing authorization for a proposed biosimilar for treatment of immune-mediated inflammatory diseases.
Read more in the news release: investors.biogen.com/news-releases/news-release-details/t… -
Biogen
@biogen
As part of our commitment to addressing unmet needs for the rare disease community, we’re pleased to share that the European Commission has approved our treatment for amyotrophic lateral sclerosis (#als) in adults with a specific gene mutation. Read more: investors.biogen.com/news-releases/news-release-details/b…
-
Biogen
@biogen
Biogen bolsters late-stage pipeline, expands immunology portfolio, with agreement to acquire @HIBiosciences. Learn more about this #news: investors.biogen.com/news-releases/news-release-details/b…
-
Biogen
@biogen
Along with @ionispharma, we are sharing an update about our investigational antisense oligonucleotide (ASO) for #als. Learn more about this #news:
-
Biogen
@biogen
Along with @EisaiUS, we’ve initiated the rolling submission of a Biologics License Application to the U.S. #fda for the investigational subcutaneous formulation of our drug for early #alzheimersdisease. Learn more about this #news: investors.biogen.com/news-releases/news-release-details/e…
-
Biogen
@biogen
We’re pleased to share that #biogen received a positive CHMP opinion from #ema for a proposed rheumatoid arthritis #biosimilar, based on a robust analytical, non-clinical and clinical data package comparing the product to the reference biologic. Read more: investors.biogen.com/news-releases/news-release-details/b…
-
Biogen
@biogen
STARTING SOON: Our Q1 2024 financial results live webcast starts at 8:30 AM ET. Register for the webcast here: event.webcasts.com/starthere.jsp?ei=1658323&tp_key=51fbae…
#earnings $BIIB -
Biogen
@biogen
Read our Q1 2024 financial results here: investors.biogen.com/news/news-releases
#earnings $BIIB -
Biogen
@biogen
The 20th #biosimilar Medicines Conference (#bios24) starts tomorrow! Join us during session 5 on Reforming EU and National Market Policies. It’s a great chance to learn about the national market dynamics that profoundly influence biosimilar competition: bit.ly/3xH1etHddd
-
Biogen
@biogen
Biogen will report Q1 financial results, April 24 before markets open in the U.S.: investors.biogen.com/news-releases/news-release-details/b…
#earnings $BIIB -
Biogen
@biogen
We’re headed to Lisbon, Portugal this week for #adpd24 (@adpdnet). We’re looking forward to sharing the latest research from our Alzheimer’s disease portfolio and connecting with the medical community. Learn more: investors.biogen.com/news-releases/news-release-details/b…
-
Biogen
@biogen
We are presenting data from ongoing studies and new updates from our spinal muscular atrophy (#sma) research at the 2024 #mdaconference. Learn more: investors.biogen.com/news-releases/news-release-details/n…
-
Biogen
@biogen
We’re proud to share CEO Chris Viehbacher was named to @statnews 2024 Status List – read more here: www.statnews.com/status-list/2024/chris-viehbacher/
STAT
@statnews
The 2024 #statuslist is officially here! See STAT's third annual list of leaders shaping the future of health and the life sciences: www.statnews.com/status-list/2024/
-
Biogen
@biogen
We’ve received a positive opinion from the European Medicine Agency’s Committee for Medicinal Products for Human Use (CHMP) for our treatment for amyotrophic lateral sclerosis (#als) in adults who have a specific gene mutation. Learn more about this news: investors.biogen.com/news-releases/news-release-details/b…
-
Biogen
@biogen
This morning we reported our Q4 and Full-Year 2023 Financial Results. See highlights from our webcast below and watch the full recording here: investors.biogen.com/events-and-presentations/upcoming-ev…
#earnings $BIIB -
Biogen
@biogen
STARTING SOON: Our Q4 and Full-Year 2023 Financial Results live webcast starts at 8:00 AM ET. Register for the webcast here: event.webcasts.com/starthere.jsp?ei=1651786&tp_key=a7ec89…
#earnings $BIIB -
Biogen
@biogen
Read our Q4 and Full-Year 2023 Financial Results here: investors.biogen.com/news/news-releases
#earnings $BIIB -
Biogen
@biogen
We’re pleased to share that we’ve received approval from the European Commission for our #friedreichsataxia (FA) therapy in people aged 16 years and older. This is the first treatment approved in the European Union for FA, a rare neurodegenerative disease: investors.biogen.com/news-releases/news-release-details/b…
-
Biogen
@biogen
Today we announced plans to reprioritize our resources in Alzheimer’s disease, a strategic therapeutic area expected to drive near and long-term growth. Read our news release: investors.biogen.com/news-releases/news-release-details/b…
-
Biogen
@biogen
It’s a common misconception that #alzheimersdisease (AD) only impacts those who are age 65+. However, early-onset AD can affect adults under this age. Watch to learn more about how age impacts those living with AD:
-
Biogen
@biogen
The progression and distribution of tau in the brain is tied to symptoms in #alzheimersdisease. Using what we know and recognizing what we don’t know about the protein is key to developing potential treatments. Read more: www.biogen.com/stories/untangling-tau.html
-
Biogen
@biogen
We’re excited to announce our participation at #acr23 in San Diego where we’ll share additional data from our #lupus research programs. Learn more about the meeting: acr23.eventscribe.net
-
Biogen
@biogen
Data from our early-stage #alzheimers disease research has been published by @JAMANeuro.
Learn more: investors.biogen.com/news-releases/news-release-details/j…
#biotechnews -
Biogen
@biogen
At Biogen, we strive for an advanced understanding of medications to ensure safety and proper use for all.
Join us during this #medsafetyweek, where we emphasize the importance of staying vigilant and reporting adverse events and reactions. who-umc.org/medsafetyweek/ -
Biogen
@biogen
This morning we reported our third quarter 2023 financial results. A replay of the webcast is now available: investors.biogen.com/events-and-presentations/upcoming-ev…
#earnings $BIIB -
Biogen
@biogen
Do you know the difference between normal signs of aging and common symptoms of #alzheimersdisease (AD)? Watch to learn more about early warning signs of AD:
-
Biogen
@biogen
Starting soon: Join our Q3 2023 financial results live webcast starting at 8 AM ET. Register for the webcast here: investors.biogen.com/news/news-releases
#earnings $BIIB -
Biogen
@biogen
Read our third quarter 2023 financial results here: investors.biogen.com/news/news-releases
#earnings $BIIB -
Biogen
@biogen
This #nationalfamilycaregiversmonth, we are proud to join @CaregiverAction in honoring those who are caring for a loved one, and advocating for greater support for the caregiver community. Learn more about this year’s #caregiversconnect campaign: www.caregiveraction.org/caregiversconnect/
-
Biogen
@biogen
Today, Biogen announced the appointment of Monish Patolawala to our Board of Directors, effective January 1. He brings 25+ years of experience leading the financial operations and business of global industrial and healthcare businesses. Read more: investors.biogen.com/news-releases/news-release-details/b…
-
Biogen
@biogen
We were pleased to receive a Corporate Visionary Award during the @LatinoDirectors 8th Annual Board Leaders Convening event. This award represents our ongoing progress toward advancing diversity, equity, and inclusion in the workplace.
www.latinocorporatedirectors.org/corporate_visionary_awar…
#teambiogen -
Biogen
@biogen
By researching the role of #tau in #alzheimerdisease, we can better understand how symptoms will present in patients and how the disease progresses. Watch more:
This media couldn't be displayed. See it on the original post. -
Biogen
@biogen
.@EisaiUS and Biogen shared new findings about our Alzheimer’s treatment at #ctad23 this week in Boston, MA. Read our news release to learn more about the progress we have made in finding options for people living with Alzheimer’s disease: investors.biogen.com/news-releases/news-release-details/e…
-
Biogen
@biogen
At Biogen, we are committed to advancing #alzheimersresearch to improve the lives of patients like Barry and their families.
Watch his inspiring story: www.youtube.com/watch?v=Jt7ONRSZxKU
#ctad23 -
Biogen
@biogen
Today at @CTADconference, we presented promising new preliminary clinical data investigating the impact of reducing tau on clinical measures in early-stage #alzheimersdisease.
Learn more: investors.biogen.com/news-releases/news-release-details/n…
#ctad23 -
Biogen
@biogen
Although much progress has been made, the need for additional #alzheimersdisease treatment options remains.
Read more about the three things to know as we lead the way in a new era of discovery and treatment: www.biogen.com/stories/alzheimers-disease-things-to-know.…
#ctad23 -
Biogen
@biogen
We are honored that two of our recent FDA approvals were selected for TIME’s 2023 Best Inventions list. Thank you @TIME for recognizing our commitment to making a difference in the lives of patients. @SageBiotech @EisaiUS
TIME
@TIME
TIME's new cover: Introducing the Best Inventions of 2023 ti.me/3FuI2Qp
-
Biogen
@biogen
We’ll be at #ctad23 in Boston! Learn more about the science we are advancing in #alzheimersresearch: investors.biogen.com/news-releases/news-release-details/b…
-
Biogen
@biogen
Congratulations to France, the #fipfapowerchairworldcup2023 champions, and all teams who competed. We are honored to support this year’s FIPFA World Cup.
#powerchairfootball #sma -
Biogen
@biogen
Nathan lives with #sma and is heading to Australia with the U.S. National #powerchairfootball Team for next week’s #fipfapowerchairworldcup2023 (Oct 15-20). As a proud sponsor of the tournament, we can’t wait to cheer on Nathan and all participating players from across the globe.
This media couldn't be displayed. See it on the original post. -
Biogen
@biogen
Biogen is gearing up for the #ectrims2023 Congress in Milan this October! Join us at booth A05 to explore the latest in #multiplesclerosis and chat with our team about important topics in the field #msmilan
-
Biogen
@biogen
Only about 15 percent of women with postpartum depression (#ppd) receive treatment. @MentalHealthAm provides free online resources to help new and expecting parents have informed discussions with their health care team. Learn more on #nationaldepressionscreeningday.
-
Biogen
@biogen
Join us in welcoming Jane Grogan, Ph.D. to Biogen as our new Head of Research.
-
Biogen
@biogen
We are proud to announce the U.S. FDA has approved our biosimilar for the treatment of inflammatory autoimmune conditions. Learn more about the U.S. FDA’s approval:
-
Biogen
@biogen
Awareness is the first step, and together, we can make a significant impact! In alignment with #worldalzmonth, we join the cause by supporting this initiative & advocating for dementia risk reduction. Explore the toolkit from @Alzdisint & learn how you can contribute this month!
ADI
@AlzDisInt
Join the global conversation on dementia risk reduction. With numbers expected to triple by 2050, every tweet, share, and like counts! 💡 #worldalzmonth #nevertooearly #nevertoolate
www.alzint.org/get-involved/world-alzheimers-month/never-… -
Biogen
@biogen
Yesterday marked International #ataxia Awareness Day (#iaad23). #friedreichsataxia, a rare brain disease that affects every part of a person’s life, is a new area of focus for Biogen. Learn more about how you can get involved in raising awareness on the @NAF_Ataxia website:
-
Biogen
@biogen
Today, we announced Biogen has completed acquisition of Reata Pharmaceuticals. Learn more about the acquisition:
-
Biogen
@biogen
Along with @Eisai_SDGs, we announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved our #alzheimersdisease investigational drug – another milestone in our journey towards advancing the science for those living with this disease. Learn more:
-
Biogen
@biogen
Together with Eisai, we are proud to join the #alzheimers community in recognizing #worldalzheimersday.
Eisai US
@EisaiUS
We’ve been committed to the #alzheimersdisease community for over four decades. Today on #worldalzheimersday, we show our commitment to serving people impacted by this devastating disease by wearing purple to raise awareness. #lifeateisai #4decadesofnevergivingup #nevertoolate
-
Biogen
@biogen
Around the world, more than 55 million people have a form of dementia – with 60-70% of cases being Alzheimer’s disease. On #worldalzheimersday and every day, we are committed to elevating the voices of the community and furthering #alzheimersdisease research.
-
Biogen
@biogen
We’re excited to attend the @LongwoodLeaders Fall Conference this week, with our very own Priya Singhal and Rachid Izzar on the ground to discuss topics impacting the biopharma landscape.
#leadership #longwoodhealthcareleaders -
Biogen
@biogen
September is Newborn Screening Awareness Month. #newbornscreening is essential for early diagnosis and treatment of #rarediseases, offering families the best chance for improved outcomes. Learn more:
#nbsawarenessmonth -
Biogen
@biogen
We recognize patient safety as a global health priority. Join us in observing #worldpatientsafetyday2023 and learn more about how we are committed to protecting patients:
-
Biogen
@biogen
According to the US Centers for Disease Control and Prevention, #mentalhealth conditions are a leading cause of maternal mortality. This #suicidepreventionawarenessmonth, we remain committed to advancing maternal mental health care.
-
Biogen
@biogen
We’re seeking applications from innovators in #neuroscience and #biotech for the Biogen-@LabCentral Golden Ticket award, which will provide a $50K credit for space at LabCentral in Cambridge. Applications are due October 6th.
-
Biogen
@biogen
Jana Dolnikova and her daughter Jana Dolnikova-Smith have worked for Biogen for more than 50 years, combined. They have worked on almost every therapy that Biogen has delivered to patients. Read about their career journeys and what inspires them every day. #teambiogen
-
Biogen
@biogen
Findings from our Phase 3 SKYLARK Study with @SageBiotech on #postpartumdepression have been published in @APA_Publishing, offering insights on #maternalmentalhealth. Learn more:
-
Biogen
@biogen
Caitlin felt disconnected from her son when he was born. Now she hopes to help others who are struggling with #postpartumdepression. #womenshealth #ppd
-
Biogen
@biogen
We are proud to announce our #postpartumdepression medicine, developed in collaboration with @SageBiotech, is now approved by the U.S. FDA. Learn more. investors.biogen.com/news-releases/news-release-details/f…
-
Biogen
@biogen
An integral part of #sma awareness is celebrating the inspiring people in the #sma community. This #smaawarenessmonth, we’re cheering on Nathan as he trains for the upcoming #fipfaworldcup2023 in Australia. Look back at how Nathan got into power soccer and what it means to him:
-
Biogen
@biogen
It’s a common misconception that adults with spinal muscular atrophy (#sma) can’t be independent or live on their own. Watch to learn more about living with SMA & different levels of supportive care. #understandingsma
-
Biogen
@biogen
Today, we announced that Biogen will acquire rare disease company Reata Pharmaceuticals. Learn more about this proposed transaction: investors.biogen.com/news-releases/news-release-details/b…
#friedreichsataxia | $BIIB | @ReataPharma -
Biogen
@biogen
Biogen is thrilled to join the #asrs2023 Annual Meeting starting tomorrow. We're eager to contribute to discussions on retinal diseases #retina #ophthalmology #vision
-
Biogen
@biogen
We were excited to host The Lady Cardinals Mentorship Program at our Community Lab last week. The summer program helps high schoolers explore #stem careers. Thank you to @NCCommerce Secretary, Machelle Baker Sanders, for this introduction. #caringdeeply
-
Biogen
@biogen
We're proud to work with @HarvardCCHANGE and @Americares to promote health equity and help provide new patient toolkits in the U.S. Given the record-breaking heat waves across the country, it’s imperative that patient care can be managed during these extreme conditions.
Harvard C-CHANGE
@HarvardCCHANGE
"... in medicine our interventions are too reactionary,” said @GaurabBasuMDMPH. “We need to be more proactive in communicating public health risks.”
Our toolkit with @Americares supported by @Biogen & heat alert system with @ClimateCentral can help.
www.americares.org/what-we-do/community-health/climate-re… -
Biogen
@biogen
Congratulations to students like Jadah who graduated from high school after participating in the Biogen Foundation-supported STAR Initiative, a program that aims to foster a lasting passion for science among diverse students. #stem #stemequity #caringdeeply
-
Biogen
@biogen
Jana Dolnikova and her daughter Jana Dolnikova-Smith have worked for Biogen for more than 50 years, combined. They have worked on almost every therapy that Biogen has delivered to patients. Read about their career journeys and what inspires them every day. #teambiogen
-
Biogen
@biogen
Along with @EisaiUS, we announced new data from our Phase 3 clinical trial in early #alzheimersdisease and the latest findings on an investigational formulation at the 2023 @alzassociation International Conference. Learn more:
#aaic23 -
Biogen
@biogen
Some say that spinal muscular atrophy (#sma) affects the brain, causing people with the disease to have trouble remembering, learning new things & making decisions. What do you think? Watch to learn more about #understandingsma:
-
Biogen
@biogen
Many unknowns remain about how #alzheimersdisease changes the brain – one of many reasons why the condition is so complex. In our recent @STATNews sponsored article, we share insights on the research that’s underway. Read the full article here:
-
Biogen
@biogen
We are honored to be recognized as a Best Place To Work for Disability Inclusion on the Disability Equality Index by @DisabilityIN for the sixth year in a row.
Read more: www.biogen.com/responsibility/reporting-and-principles/es…
#bestplacetowork #disabilityinclusion #disabilityequalityindex -
Biogen
@biogen
We are proud to share that #biogen in collaboration with @corevitasdata won a “Best Use of Innovation” Award in BHBIA BOBI 2023 for ‘Rethinking Pathways: A Simulation-Based Approach to Evidence-Driven NHS Planning’ @BHBIAssociation #bhbia #bobiawards2023
-
Biogen
@biogen
Tune in to the @NESN @RedSox pre-game show today to hear Teresa Cachero, Board Chair of the Biogen Foundation, discuss our support of the @RedSoxFund’s Scholars program! #scienceeducation #caringdeeply #gosox
-
Biogen
@biogen
Along with @EisaiUS, we announced that the U.S. #fda has approved our #alzheimersdisease investigational drug – another step in our journey toward advancing the science for those living with this disease. Learn more:
-
Biogen
@biogen
Congrats to our President & CEO, Chris Viehbacher, on joining the Life Science Cares Boston Board of Advisors. @LS_Cares uses the power of the life science industry to make a positive impact in the community and has been a great partner for Biogen for many years. #lscimpact
Life Science Cares
@LS_Cares
Welcome Chris Viehbacher, President & CEO at @biogen, to the LSC Boston Board of Advisors! We're thrilled to add Chris' deep experience in industry with his passion for making an impact! #lscimpact
-
Biogen
@biogen
Heartfelt congratulations to Biogen Board member Maria Freire who has been named to the @CarnegieCorp 2023 Great Immigrants list. Maria’s achievements in healthcare are inspiring and serve as a testament to the positive impact immigrants bring to the U.S. #greatimmigrants
-
Biogen
@biogen
Excited to announce our participation at the 9th Congress of the European Academy of Neurology (#ean23). Biogen Digital Health will be hosting a satellite symposium on the potential of digital technology to transform drug development in neurology. @EANeurology #neurology
-
Biogen
@biogen
At this year’s @CureSMA #2023smaconference, we are presenting new data from ongoing studies and updates from our #sma research. Learn more:
-
Biogen
@biogen
Biogen employees from Boston to Zurich were thrilled to participate in Pride Month. Pride parades, volunteering and learning sessions help us celebrate all that the LGBTQ+ community contributes. We can’t hide our pride! www.biogen.com/responsibility/reporting-and-principles/es…
#pridemonth #lgbtq #dei -
Biogen
@biogen
Every year we look forward to coming together at the @CureSMA 2023 Annual SMA Conference to hear directly from the people who inspire everything we do. Kristen Fortino, Head, U.S. Rare Disease Franchise, shares the importance of connecting at the #2023smaconference:
-
Biogen
@biogen
Some people may think spinal muscular atrophy (#sma) is always a fatal disease. Advances in SMA screening and innovation aim to improve outcomes in those diagnosed early in life, with the more rapidly progressing types of SMA. Watch to learn about #understandingsma.
-
Biogen
@biogen
Congratulations to Biogen Board member Maria Freire for being named to Carnegie Corporation of New York’s 2023 Great Immigrants list. Maria has been a champion for public health and strengthened the global healthcare and scientific industries. Join us in celebrating Maria!
Andrew Carnegie Foundation
@ACarnegieFdn
Immigrants contribute pioneering discoveries, protect our country, bring stories to life, empower next-gen leaders, defend human rights, make us break out in song, help our children thrive & build opportunities for others.
Meet the 2023 #greatimmigrants.🎉 carnegie.io/44g1x9y -
Biogen
@biogen
Last year, we had the privilege of meeting Nathan and learning about his unique journey with #sma and his passion for power soccer. This year, we look forward to cheering him on as he trains for the #fipfaworldcup2023 in Australia. This is Nathan’s message:
-
Biogen
@biogen
We’re excited to welcome our summer 2023 intern class. We have partnered with several organizations and universities to welcome students from a broad range of experiences and backgrounds who aspire to become tomorrow’s leaders in #biotechnology. #teambiogen
-
Biogen
@biogen
On #thelongestday, we remain committed to furthering #alzheimersdisease research to help improve the lives of those living with Alzheimer's. Watch Barry’s story:
-
Biogen
@biogen
Today on Global ALS/MND Awareness Day, we are proud to join the International Alliance of ALS/MND Associations (@ALSMNDAlliance) in recognizing those living with ALS/MND and their caregivers. We remain dedicated to advancing science and research globally. #alsmndwithoutborders
-
Biogen
@biogen
Excited to announce our participation at the European Paediatric Neurology Society (EPNS) Congress. We will be sharing our latest research and insights for pediatric neurological disorders #epns2023 #pediatricneurology
-
Biogen
@biogen
Some people may believe spinal muscular atrophy (#sma) is a disease that only occurs in infants and young kids. In fact, SMA can be diagnosed in teens, young adults and older adults. Watch to learn common misperceptions about SMA. #understandingsma
-
Biogen
@biogen
Barry and Randy vowed to be together for better or worse. When Barry was diagnosed with #alzheimersdisease their life ahead was suddenly a blur.
This #pridemonth we honor their journey as they brave the disease together. -
Biogen
@biogen
Along with @EisaiUS, we announced a positive update on the outcome of the #fda Advisory Committee Meeting for our #alzheimersdisease investigational drug. Read more here:
-
Biogen
@biogen
There may be questions about how an inherited disease like spinal muscular atrophy (#sma) could get passed down from parent to child. Learn more about the genetics of SMA. #understandingsma
-
Biogen
@biogen
Join Endpoints at #bio23 for a virtual panel discussion today at 1PM ET with Priya Singhal, our Head of Development. Pharma R&D leaders will delve into the business strategy of drug development and commercialization. bio23.endpts.com
-
Biogen
@biogen
Biologic medicines can support the sustainability of our healthcare systems and increase patient access. Learn more in an interview in @Parlimag with Dan Cohen, Vice President and Head of the Biosimilars Unit, who shares his perspectives on the potential of #biosimilars.
-
Biogen
@biogen
This #pridemonth and always, we celebrate our #lgbtq+ colleagues and the LGBTQ+ community for their invaluable contributions to our company and society.
-
Biogen
@biogen
We are excited to join @mscare at #cmsc2023 where we’ll share our latest #multiplesclerosis research and host a first night symposium about “Why we came and why we stayed: A conversation with the Oldies, the Goodies, and the Newbies!" Learn more:
-
Biogen
@biogen
At Biogen, we are proud to participate in World MS Day and support the MS community in celebrating people living with and affected by the disease around the world. Find out more about #worldmsday:
-
Biogen
@biogen
The 19th Biosimilar Medicines Conference (#bios23) starts today and we're proud to be part of the discussion on advancing the regulatory process for #biosimilarmedicines. Join our three engaging sessions with Biogen speakers to learn more and help shape the future of healthcare.
-
Biogen
@biogen
Join us in Amsterdam on May 25-26 for three insightful sessions featuring Biogen experts at the 19th Biosimilar Medicines Conference. Learn about "The Future is Biologic: Strengthening Biosimilar Policy for Better Health in Europe." #bios23 #biogen #eupharma #biosimilarmedicines
-
Biogen
@biogen
There may be a misperception that people living with spinal muscular atrophy (#sma) are not able to care for children due to the physical challenges associated with their disease. Learn more to #getsmartaboutsma:
#understandingsma -
Biogen
@biogen
On #clinicaltrialsday, we thank those who conduct and participate in clinical trials to further scientific advancements. Clinical trials play a crucial role in helping us try to pioneer breakthrough innovations that can help improve patients’ lives. #ctd2023
-
Biogen
@biogen
Amyotrophic lateral sclerosis (#als) is a universally devastating disease in all its forms. Close to 15% of all ALS cases are associated with a known genetic mutation.
#alsawarenessmonth -
Biogen
@biogen
You may think that sports are only meant for “able-bodied” people. However, thanks to adaptive sports programs like power soccer, many people with a neuromuscular disease like #sma can find a physical activity they enjoy. Learn more:
#getsmartaboutsma #understandingsma -
Biogen
@biogen
Kate was diagnosed with amyotrophic lateral sclerosis (ALS) a week before her 33rd birthday, changing the course of her life. Hear more from Kate on how she’s gained newfound passion and inspiration as an #als advocate. #alsawarenessmonth
-
Biogen
@biogen
Each year, May marks #healthyvisionmonth and we are raising awareness about the importance of #visionhealth.
#biogen #visionmatters -
Biogen
@biogen
After Caitlin had her first baby, she thought the experience she was having was the “normal baby blues.” Leading up to #mothersday, Caitlin shares her postpartum journey to offer hope to new mothers like her. #mham #maternalmentalhealth
-
Biogen
@biogen
This International Nurses Day, we appreciate nurses worldwide for the critical role they play in an individual’s health journey and for working to improve global health for all. Thank you to all nurses for the meaningful difference you make each day! #ournursesourfuture #ind2023
-
Biogen
@biogen
People often assume that those impacted by spinal muscular atrophy (#sma), a progressive neuromuscular disease, may not be able to pursue a career. What do you think? Watch to #getsmartaboutsma and learn the facts about SMA and employment. #understandingsma
-
Biogen
@biogen
Lupus can look different from person to person, making it hard to recognize the signs. This #worldlupusday, hear from Jada who shares her story to empower people to know the signs and symptoms of the disease and to be their own advocate.
-
Biogen
@biogen
We invite you to join two sessions at the 2023 International Society for Pharmacoeconomics and Outcomes Research (#ispor2023) annual conference focusing on the potential cost-saving impact relating to use of #biosimilars in the UK and Canada: www.ispor.org/conferences-education/conferences/past-conf…
-
Biogen
@biogen
Mental health stigma can cause those living with depression to feel ashamed and isolated. Hear from our colleague Monica on her family’s battles with depression and her efforts to encourage acceptance for those living with or impacted by the disease. #mentalhealthmonth #mham
-
Biogen
@biogen
The International Society for Pharmacoeconomics and Outcomes Research (#ispor2023) annual conference runs from 7-10th of May. If want to learn more about the market dynamics post #immunology #biosimilars entry in the EU, join our session: www.ispor.org/conferences-education/conferences/past-conf…
-
Biogen
@biogen
We’re proud sponsors of the @alzheimersmanh 11th Annual Hope on the Harbor gala, bringing together key industry leaders to support the #alzheimersdisease (AD) community. Learn more about the event here:
-
Biogen
@biogen
Some people may think if you have a progressive disease like spinal muscular atrophy (#sma), you cannot be in a romantic relationship. Learn more to #getsmartaboutsma:
#understandingsma -
Biogen reposted
Biotechnology Innovation Organization
@IAmBiotech
Hear insights and strategies from biotech leaders like @biogen's CEO, Chris Viehbacher, at the BIO International Convention! Make sure you catch these influential speakers amongst the other robust programming at #bio2023.
www.bio.org/events/bio-international-convention/sessions -
Biogen
@biogen
This May, #teambiogen is gearing up to run, walk, swim or cycle 50 km (or more!) as part of MS International Federation's (@MSIntFederation) #themay50k challenge.
#leaveyourlimitsbehind -
Biogen
@biogen
As a purpose-driven organization, we believe our business is a force for good. Our newly released 2022 #esg Report highlights how we continue to serve humanity through science while advancing a healthier, more sustainable and equitable world. #corporateresponsibility
-
Biogen
@biogen
We are honored to share that @NaturePortfolio has published data from our early-stage #alzheimers disease research that was previously presented at the 2023 AD/PD (@adpdnet) conference. Learn more:
#biotechnews -
Biogen
@biogen
Some may believe that people living with spinal muscular atrophy (#sma) are unable to achieve the same educational goals and milestones as those without a rare disease. #getsmartaboutsma and learn more:
#understandingsma -
Biogen
@biogen
Our development partner, @SamsungBioepis, presented new data from the Phase 3 Study for a proposed #ophthalmology #biosimilar, at the 2023 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting: www.samsungbioepis.com/en/newsroom/newsroomView.do?idx=32…
-
Biogen
@biogen
Researchers have found that levels of neurofilament predict how neurological diseases like #als may progress. Learn how #neurofilament can help inform how ALS is managed.
-
Biogen
@biogen
The climate crisis is a health crisis. This #earthday, we recognize we must #investinourplanet and reduce the environmental impact of our products and operations. Read more about Biogen’s environmental efforts:
-
Biogen
@biogen
Our bodies have a network of ~100 billion neurons which helps us walk, talk & breathe among hundreds of other daily activities. #neurofilaments are a type of structural protein found in neurons. Learn how neurofilament is elevated in many neurodegenerative diseases, like #als:
-
Biogen
@biogen
We’re excited to be part of the #aanam 2023 annual meeting. Join us virtually or in Boston (Booth #2155) to learn more about our new #neurology data and attend upcoming booth talks and presentations. View the program:
-
Biogen
@biogen
We are pleased to announce that our development partner, @SamsungBioepis, will present new results from the Phase 3 study for a proposed #ophthalmology #biosimilar at the 2023 Association for Research in #vision and Ophthalmology (#arvo) Annual Meeting
-
Biogen
@biogen
Help us give a warm welcome to Adam Keeney, Ph.D., our new Head of Corporate Development. With more than 20 years of biotech industry experience, we look forward to having Adam as a part of our leadership team. Read more:
#biotechnews #innovation -
Biogen
@biogen
Together with Denali Therapeutics, we announced an agreement to develop and commercialize an antibody transport vehicle program targeting amyloid beta. Read more:
-
Biogen
@biogen
When Alison was diagnosed with #parkinsonsdisease as a fit 50-year-old, she was devastated and angry. This #worldparkinsonsday and during #parkinsonsawarenessmonth, hear from Alison on how she’s taking control of her life.
-
Biogen
@biogen
Tomorrow is the final day to apply to the Biogen Worldwide Medical Ph.D. Fellowship. Apply today with a resume and cover letter combined into a single .pdf file to prepare for a career in the biotech industry:
-
Biogen reposted
Lupus Research
@LupusResearch
Lupus Accelerating Breakthroughs Consortium is determined to find better ways to treat people with lupus. Learn more at lupusabc.org. #lupus #lupusvoices #lupusabc
-
Biogen
@biogen
#dyk: Researchers have linked specific symptoms of #alzheimers disease (AD) to where #tau deposits occur in the brain. Hear from our Head of Biomarkers on technologies that allow us to see inside the brain. #adpd2023
-
Biogen
@biogen
Today, we announced new biomarker data from our investigational anti-tau treatment for #alzheimers disease at the 2023 International AD/PD (@adpdnet) Conference. Learn more:
#adpd2023 -
Biogen
@biogen
Our own Priya Singhal, M.D., M.P.H., Head of Development, shares her career journey and the decision to put it on hold to raise her children, the mentors who supported her along the way, and why she doesn’t believe in bucket lists. #womenshistorymonth2023 #herstory
-
Biogen
@biogen
Tracy, living with MS since 2007, wants her daughter to grow up knowing that she can move forward with her dreams no matter what. This #msawarenessmonth, we share the unique perspectives and experiences of those living with #multiplesclerosis.
-
Biogen
@biogen
Individuals with genetic amyotrophic lateral sclerosis (ALS) are profoundly impacted by this neurodegenerative disease.
Our dedication to developing therapeutics for #geneticals is inspired by people like Jeremy, who fearlessly battle ALS and strive to spread awareness. -
Biogen
@biogen
Our production site in Solothurn, Switzerland, was awarded ISO Certifications for Environmental Management Systems and Occupational Health and Safety Management Systems.
We continue to #caredeeply for the well-being of our employees and the environment. -
Biogen
@biogen
Cancer specialists have used biomarkers to aid in the identification and treatment of disease. #neurofilaments – another type of biomarker – could help us understand complex #neurological conditions. Read more:
-
Biogen
@biogen
On #internationalwomensday, we celebrate the achievements of women and stand together in solidarity for gender equity. This year, and every year, we #embraceequity by fostering a diverse and inclusive environment.
-
Biogen
@biogen
We are pleased to announce that Caroline Dorsa, a member of the #biogen Board of Directors since 2010, will succeed Stelios Papadopoulos, Ph.D., as Chair of the Biogen Board of Directors. Read more:
#biotechnews #innovation -
Biogen
@biogen
This #womenshistorymonth we celebrate all women and their contributions to science and society. Learn more about our commitment to build a culture of inclusion and belonging.
#womenshistorymonth2023 #herstory -
Biogen
@biogen
Our President & Chief Executive Officer, Christopher A. Viehbacher, will be participating in the Cowen 43rd Annual Healthcare Conference. Watch the webcast live on March 6 at 9:50 AM ET. #cowenhealthcare $BIIB
-
Biogen
@biogen
Today on #rarediseaseday we are proud to join @RareDiseases, @eurordis & @rarediseasesint in raising awareness of the rare disease movement, which includes ensuring equity for people living with a #raredisease. Learn more:
-
Biogen
@biogen
#biosimilar use in Europe continues to grow and deliver more patient treatment days to the #healthcare system year over year. #biogen #biogenbiosimilars
-
Biogen
@biogen
Today, we announced a collaboration with Mila, the Quebec Artificial Intelligence Institute (@Mila_Quebec), with a goal of driving forward artificial intelligence and machine learning innovation in therapy development. #biogen #biogendigitalhealth #neuroscience #biotechnology
-
Biogen
@biogen
Congratulations to our 2022 “Golden Ticket” winners, Transcera and Cerberus Therapeutics! We are proud to support local #biotech startups through our annual “Golden Ticket” program, granting winners credit for space at @LabCentral in Cambridge.
-
Biogen
@biogen
This #nationalcaregiversday, we honor caregivers like Heidi, who cares for her 19-year-old son William who was diagnosed with SMA at age one.
-
Biogen
@biogen
Tomorrow’s virtual session will provide information about our Worldwide Medical Ph.D. Fellowship, potential careers in medical affairs, and navigating a transition to the biotech industry. To RSVP, fill out this form today:
-
Biogen
@biogen
This #blackhistorymonth we honor and celebrate the African American and Black communities.
We are committed to fostering a culture of inclusion reflecting the diverse communities where we work and the patients we serve. -
Biogen
@biogen
On International Day of Women and Girls in Science, we applaud all the girls pursuing #stem careers.
#womeninscience -
Biogen
@biogen
Fewer than one-third of people living with #depression receive adequate treatment. We are committed to driving innovation in depression care and working to pioneer solutions for those living with this difficult disease.
-
Biogen
@biogen
Our #coopprogram offers invaluable experience in the biotech industry, enabling students to connect their academic achievements with their career aspirations.
-
Biogen
@biogen
Join us for an informational session about our two-year Worldwide Medical Ph.D. Fellowship. To RSVP and gain perspective on a potential career in the biotech industry, please complete this form by February 14:
-
Biogen
@biogen
Along with @SageBiotech, we announced today that the FDA has accepted the New Drug Application (NDA) and granted priority review for our investigational therapy for #mdd and #ppd. Learn more:
-
Biogen
@biogen
Our fundamental values create a culture that encourages collaboration and strives to ensure employee voices are heard.
#teambiogen -
Biogen
@biogen
Applications are open for our Worldwide Medical Ph.D. Fellowship program for doctoral graduates. Apply with a resume and cover letter combined into a single .pdf by March 31 for an opportunity to learn the ins and outs of the biotech industry:
-
Biogen
@biogen
We work alongside colleagues from all backgrounds who share a passion for caring deeply, working fearlessly and changing lives.
#teambiogen -
Biogen
@biogen
#alzheimers has changed Greg’s personality, forcing him to rely on strategies to cope with social situations and leaving him feeling isolated and afraid. Learn more about his story.
-
Biogen
@biogen
Through our recently announced agreement with @AlcyoneTX we aim to develop a novel implantable device intended for subcutaneous intrathecal delivery of ASOs and explore its potential to improve the patient experience and access to treatment.
Read here: investors.biogen.com/news-releases/news-release-details/b… -
Biogen
@biogen
In 2022, guided by our purpose to make a difference in people’s lives, we drew our inspiration from those living with some of the most complex diseases.
-
Biogen
@biogen
As part of our longstanding anti-CD20 collaboration with @genentech, today we announced an agreement on the potential commercialization of a late-stage bispecific antibody within the United States.
-
Biogen
@biogen
Today, we announced the FDA Filing Acceptance of our rheumatology #biosimilar candidate. Phase 3 results were presented at the ACR (American College of Rheumatology) 2022 Annual Meeting. #biogen
-
Biogen
@biogen
This October, scientists were awarded the 2022 Nobel Prize for “click chemistry,” a cutting-edge technique in #neurotechnology. Our own Brendon E. Cook and Thomas Pickel explain how they apply this approach to drug development today. Read more:
-
Biogen
@biogen
Today, with @SageBiotech, we announced the completion of the rolling submission of a New Drug Application to the U.S. FDA for major depressive disorder and postpartum depression. Learn more:
-
Biogen
@biogen
Together with @SageBiotech we will host a live #investor webcast on Dec. 6 at 8 AM ET to discuss the potential commercialization approach and opportunity for our investigational depression therapy.
-
Biogen
@biogen
ICYMI: yesterday, along with @EisaiUS, we announced the full results from our confirmatory Phase 3 Clarity AD study in #alzheimers at #ctad22.
-
Biogen
@biogen
We work to make a difference in the lives of people affected by Alzheimer’s disease, and we get to do it with people like Samantha who share our purpose.
-
Biogen
@biogen
Sudden and severe personality changes may be an early warning sign of #alzheimers. This #alzheimersawarenessmonth, learn how to recognize the early signs and symptoms in loved ones. #nationalfamilycaregiversmonth
-
Biogen
@biogen
We are delighted to announce that the Care+ mobile app has been recognized as a winner for the 2022 @RE_Pharma Awards Europe in the category of “Most Valuable Digital Therapy Award.”
Congratulations to our Biogen Biosimilars team for such a great achievement! #repawards -
Biogen
@biogen
During #nationalfamilycaregiversmonth, we honor those who are caring for someone living with #lupus. This role can often be challenging and it’s important that caregivers build their own support teams to take care of themselves. #caregivinghappens
-
Biogen
@biogen
Working to make a difference in the lives of those affected by Alzheimer’s disease is part of our purpose – this Alzheimer’s Awareness Month, and always. Our work is for Greg.
-
Biogen
@biogen
Caring for someone living with #multiplesclerosis (MS) can be very fulfilling – but it's important for each #caregiver to focus on their own well-being. This #nationalfamilycaregiversmonth, let’s show gratitude for those who support the ones they love when #caregivinghappens.
-
Biogen
@biogen
#biosimilars increase access to established biologic therapies. At Biogen, we aspire to deliver safe alternative treatment options for people affected by various conditions. Join us in celebrating #globalbiosimilarsweek.
#gbw22 #biosimilarsaccess #biosimilarsvalue -
Biogen
@biogen
Our Head of Global Biosimilars, Ian Henshaw, will be discussing the importance of #biosimilars to enable long-term #sustainability of healthcare systems in a virtual panel discussion organized by @euronews. Register and watch the live discussion on November 15th.
-
Biogen
@biogen
This November, we honor #raredisease caregivers for their tireless support and dedication during #nationalfamilycaregiversmonth. It’s through their devotion and commitment that spinal muscular atrophy (#sma) families receive the care and support they need. #caregivinghappens
-
Biogen
@biogen
We are pleased to announce the appointment of Christopher A. Viehbacher as our new President and Chief Executive Officer and a member of the Board of Directors.
-
Biogen
@biogen
Last week we presented our latest data in SOD1 amyotrophic lateral sclerosis (#als) for the first time at a U.S. congress. We enjoyed engaging with the community at #neals2022 on some of the most difficult research challenges in #neuroscience. Learn more:
-
Biogen
@biogen
Did you know that approximately 1 in 10 people age 65 and older suffer from #alzheimers? Learn more about the prevalence of this disease and its impact on society.
-
Biogen
@biogen
If you are attending the 14th Biosimilars Global Congress 2022 Europe (#bgc2022), please join our presentation on access inequalities, the concept of #biosimilarity, the impact of #biosimilars on healthcare savings and other related topics.
#biogenbiosimilars -
Biogen
@biogen
We are honored to share that the poster presented by our development partner @SamsungBioepis at the American Academy of Ophthalmology (#aao2022) Annual Meeting has been recognized by AAO as Best Poster.
#biosimilars #ophthalmology #retina #biogenbiosimilars -
Biogen
@biogen
We are proud to work with colleagues like Alex, who share our purpose of inspiring the next generation of scientists.
-
Biogen
@biogen
After closing for two years due to the pandemic, our Community Lab is safely opening for in-person learning again.
Learn more about our Community Lab here. www.biogen.com/en_us/virtual-community-lab.html?cid=osm-t… -
Biogen
@biogen
Last week our Chief Medical Officer Maha Radhakrishnan shared her perspective on what needs to be done across industries and sectors to increase health equity and ensure a more inclusive approach to medicine. Watch the replay from the @GalienFdn here: youtu.be/wtqqUTc1ZFs
-
Biogen
@biogen
Quantitative vs Qualitative data.
Going beyond the numbers of science, strong research also strives to understand the complexities of living with Multiple Sclerosis (MS).
That’s why we are thankful to Katt for sharing her personal experience about living with MS. -
Biogen
@biogen
When Kim woke up on the bathroom floor, she thought she had fainted. She never considered she may have had a #stroke at age 33. This #worldstrokeday, learn more about Kim’s story and Biogen’s research efforts to help address current treatment gaps.
-
Biogen
@biogen
This #worldpsoriasisday, we are raising awareness about the impact that #psoriasis has on people living with this condition and the importance of early diagnosis. www.ifpa-pso.com
#biosimilars #biogenbiosimilars -
Biogen
@biogen
#stroke is similar to a plumbing problem: The blood vessels leading to the brain become blocked or broken like pipes. This #worldstrokeday, learn more from Josh Bell, M.D., Ph.D., Medical Director at Biogen on how a stroke can happen.
-
Biogen
@biogen
Congratulations to the winners of the @GalienFdn #prixgalien Golden Jubilee Awards recognizing the most innovative products in the past 50 years. We were honored to attend the awards ceremony where our #sma therapy received a silver medal in the orphan/rare disease category:
-
Biogen
@biogen
This group is inspired by scientists, but we’re inspired by them.
That’s why we’re so excited to be part of the conversation during #ectrims2022, amplifying the voices of the people living with MS who drive our research. -
Biogen
@biogen
Research must be inclusive, whether that’s looking at ethnicity, gender or severity of disease.
Patient advocacy group @shiftms teamed up with MSers Sarah, David, Katt and Tia to hear what they have to say about inclusive research in #multiplesclerosis. -
Biogen
@biogen
Working to make a difference in the lives of those affected by lupus is part of our purpose. Our work is for Jada, who was diagnosed with lupus at 24 years old.
-
Biogen
@biogen
Enabling innovative approaches aimed at personalizing #multiplesclerosis (MS) care is a continued pursuit of our #digitalhealth initiatives. Watch to learn more about our real-world data being presented at #ectrims2022 focused on advancing this goal.
-
Biogen
@biogen
We are working to realize a future where data is more readily leveraged to improve the lives of people living with #multiplesclerosis (MS). Read our news release to learn more about our digital health advancements. #ectrims2022
-
Biogen
@biogen
We are pleased to present new data from across our portfolio of #multiplesclerosis (#ms) therapies at #ectrims2022. Read more:
-
Biogen
@biogen
We are honored to share that our spinal muscular atrophy (#sma) therapy was nominated by the @GalienFdn as one of the best orphan/rare disease products in the last 50 years. Learn more: #prixgalien
-
Biogen
@biogen
We look forward to sharing our latest #multiplesclerosis (MS) research at the #ectrims2022 Congress. HCPs: Join us virtually or in Amsterdam at booth #a30 in hall 10 to learn more about our new data and upcoming presentations. View the program:
-
Biogen
@biogen
Thank you to @RepChynahTyler for visiting our Community Lab this #massstemweek to inspire students about the potential of science education. Together, we can foster the next generation of diverse scientists and innovators.
-
Biogen
@biogen
We are excited to be at the @SMAEurope 3rd International Scientific Congress on Spinal Muscular Atrophy (#sma) in Barcelona, meeting with community members and colleagues who are passionate about advancing research and development for SMA. #smacongress2022
-
Biogen
@biogen
This #massstemweek, we’re excited to announce our collaboration with @IgniteLC, building upon the Biogen Foundation STAR initiative. The program has already inspired 4,000 diverse students in Massachusetts.
-
Biogen
@biogen
Thank you #fh22 for the opportunity to discuss the future of digital health with like-minded innovators. #biogendigitalhealth #digitaltherapeutics
Frontiers Health
@FrontiersHealth
Building an effective #digitaltherapeutics is one thing. Rolling it out, totally different story. Listen to the lessons learned from healthcare leaders on the forefront of #dtx in a panel moderated by @kristinmilburn from @healthware_intl
-
Biogen
@biogen
We work to make a difference in people’s lives and we get to do it with people like Weihong who share our purpose.
-
Biogen
@biogen
Yesterday with @SageBiotech, we presented further analysis of our Phase 3 SKYLARK study in #postpartumdepression. HCPs: Learn more. #ecnp2022
-
Biogen
@biogen
HCPs: We’re attending #wms2022 this week. We are sharing updates on our spinal muscular atrophy (#sma) research, hosting a symposium on rethinking the science of SMA and hearing from the #neuromuscular community. Learn more about the program agenda:
-
Biogen
@biogen
Working to make a difference in the lives of those affected by SMA is part of our purpose. Our work is for Nathan.
-
Biogen
@biogen
Did you know that today is World Sight Day? With our Biosimilars Unit, we are helping to raise awareness as to why it is so important to #loveyoureyes
-
Biogen
@biogen
HCPs: We look forward to attending #ecnp2022 this weekend, where we’ll be presenting further analysis from our Phase 3 SKYLARK study in #postpartumdepression with @SageBiotech. Hope to see you there: www.ecnp.eu/Congress2022/ECNPcongress
-
Biogen
@biogen
Thank you @medicinesforEU for organizing a panel discussion on supporting access to affordable medicines in Europe and for inviting our own Magnus Bodin as one of the panelists. We look forward to continuing to work together to improve access for patients #bios22
Medicines for Europe
@medicinesforEU
We would like to sincerely #thank all those who joined us for #bios22!
The update of the EU #pharmalegislation is around the corner & it's our goal to make it fit for #biosimilarmedicines🧪 -
Biogen
@biogen
On #worldarthritisday, we are proud to support the rheumatoid arthritis community and to help raise awareness about the importance of early detection #dontdelayconnecttoday #wad www.eular.org/world_arthritis_day.cfm
-
Biogen
@biogen
What do more than 1,000 acts of service look like? See how our employees made a difference volunteering across the globe during our 20 Days of #caringdeeply in our communities.
This media couldn't be displayed. See it on the original post. -
Biogen
@biogen
#worldmentalhealthday is about raising awareness of mental health issues around the globe. Today and every day, we are focused on transforming the care of #depression and exploring unmet #mentalhealth needs. #wmhd2022
-
Biogen
@biogen
As a founding member of @DavosAlzheimers (DAC), we remain committed to helping advance health equity for people living with #alzheimers. Learn more about the work DAC is doing to increase representation of diverse populations in Alzheimer’s research as covered on the @TODAYshow:
-
Biogen
@biogen
We work to make a difference in people’s lives and we get to do it with people like Fraser who share our purpose.
-
Biogen
@biogen
Biogen is a proud sponsor of the 18th #bios22 under a theme of “Translating the Pharmaceutical Legislation into Access & Affordability”. Join us at this in-person event to find out how #biosimilars can unlock more advanced integrated care for patients. #biogen
-
Biogen
@biogen
Join us tomorrow night for the @CambSciFest keynote panel from 7pm to 8pm as we discuss how climate impacts the health of our communities with MIT, the Environmental League of Massachusetts and the Charles River Conservancy.
-
Biogen
@biogen
During his time at the Biogen Community Lab, Juan Rafael began sketching a prototype for a motorized silicone glove to help his father, diagnosed with Parkinson’s disease, increase mobility in his hand. Now, he’s exploring other ways to help those living with mobility challenges.
-
Biogen
@biogen
Today we announced the #ema Filing Acceptance of a #rheumatology #biosimilar candidate. The application includes Phase 3 data, which were presented at the European Congress of Rheumatology in June 2022
-
Biogen
@biogen
#newbornscreening for spinal muscular atrophy (#sma) is critical for early detection and intervention. As of today, 97% of babies born in the US are now screened for SMA at birth. #nbsawarenessmonth
-
Biogen
@biogen
Addressing diversity in clinical trials is key to advancing health equity. Our latest Alzheimer’s news represents progress toward greater representation of Hispanic and African Americans living with early Alzheimer’s disease.
-
Biogen
@biogen
The U.S. burden of #alzheimers and related #dementias is expected to double by 2060. Learn more about the prevalence of this disease and its projected impact on future generations.
-
Biogen
@biogen
Today, along with @EisaiUS, we shared the Phase 3 data from our ongoing research in #alzheimers. Read more:
-
Biogen
@biogen
Our employees are addressing #climatechange in the workplace. Tooba Gilani is #gettingitdone with the @My_Green_Lab program to address sustainability in all our lab spaces.
-
Biogen
@biogen
Today our development partner @SamsungBioepis Co., Ltd. announced that they will present at the American Academy of Ophthalmology (#aao) 2022 Annual Meeting three scientific abstracts relating to its #ophthalmology #biosimilar portfolio.
-
Biogen
@biogen
Two years ago, we launched our commitment to tackling climate change through Healthy Climate, Healthy Lives™. This #climateweeknyc, we share how we’re #gettingitdone.
-
Biogen
@biogen
#biosimilars may lower #healthcare system costs broadly, creating headroom for innovation and enabling more patients to have access to therapies. www.biogen.com/en_us/stories/biosimilars-innovation.html?…
#biogen #biosimilars #healthcare -
Biogen
@biogen
The climate crisis is a health crisis. With @HarvardCCHANGE and @Americares, and recognition from the Clinton Global Initiative, we are bringing climate resiliency to health clinics worldwide.
-
Biogen
@biogen
September is #worldalzmonth. We’re proud to partner with @AlzDisInt to raise awareness of warning signs and highlight the need for support for people living with Alzheimer’s and other dementias. #knowdementia #knowalzheimers #worldalzday
-
Biogen
@biogen
Today with @SageBiotech, we shared data from our ongoing research in Major Depressive Disorder and Postpartum Depression. #psychcongress2022
-
Biogen
@biogen
We recognize patient safety as a global health priority. Join us in observing #worldpatientsafetyday2022 and learn more from @WHO. www.who.int/campaigns/world-patient-safety-day
-
Biogen
@biogen
Thank you to our teams in Italy, the UK, France and Poland who contributed to Biogen’s recognition as one of the best 25 Multinational companies in Europe by #greatplacetowork. We are grateful to all our employees around the world who truly make Biogen a great place to work.
-
Biogen
@biogen
We’re seeking applications from innovators in #neuroscience and #biotech for the Biogen-@LabCentral Golden Ticket, which will provide a $50K credit for space at LabCentral in Cambridge. Applications are due Sept. 16.
-
Biogen
@biogen
We’re passionate about supporting the #sma community and helping people along their journey. New innovations in the past few years have redefined what it means to live with SMA. Hear what inspires and gives us hope as we close out #smaawarenessmonth:
#getsmartaboutsma -
Biogen
@biogen
When Nathan was diagnosed with spinal muscular atrophy (#sma) at a young age, there was uncertainty about his future. By competing in a sport independently, Nathan goes beyond what’s expected and proves that he is not defined by his diagnosis. #getsmartaboutsma #smaawarenessmonth
-
Biogen
@biogen
We’re launching a new Biogen Community Lab Alumni Network on LinkedIn. Join today to access resources for education, internships and career development with more than 61,000 current & past participants.
-
Biogen
@biogen
We are proud of our longstanding partnerships with patient advocacy groups across the globe to spread awareness of spinal muscular atrophy (#sma). This #smaawarenessmonth, we applaud their efforts to help people #getsmartaboutsma and pioneer change for the community.
-
Biogen
@biogen
.@MassGovernor just signed a #climate plan that bolsters clean energy. We know that tackling #climatechange will take all of us and are proud to work toward going fossil fuel free, both in Massachusetts and beyond.
-
Biogen
@biogen
#tbt to 2002, when we formally committed to giving back to the communities where we live and work. We’re proud to celebrate 20 years of #caringdeeply through the Biogen Foundation!
-
Biogen
@biogen
August is #smaawarenessmonth, a time to recognize the individual and collective achievements of the spinal muscular atrophy (#sma) community. Throughout the month, we’ll be sharing more information about this rare, genetic, neuromuscular disease to help you #getsmartaboutsma:
-
Biogen
@biogen
Learn more about our data being presented at the @alzassociation International Conference. #aaic22
-
Biogen
@biogen
Overall wellness plays a critical part in our employee productivity and satisfaction. We are providing a mid-summer break so that our team can focus on the things that nourish their personal well-being. Happy Wellness Week to our colleagues around the world. #employeebenefits
-
Biogen
@biogen
We look forward to attending the @alzassociation International Conference #aaic22 next week. Learn more about the conference and register today:
-
Biogen
@biogen
Thank you to @JustCapital for recognizing our continued work to support healthy families and communities. We’re proud to be ranked 12th on this list of industry leaders who are making a difference.
Just Capital
@JustCapital
The crises of the last few years have laid bare the crucial role companies have to play in strengthening the health of communities. See which companies are leading on key issues in our #100forhealthyfamilies and #communities list:
justcapital.com/news/top-100-u-s-companies-supporting-hea… -
Biogen
@biogen
#climatechange demands action from everyone, which is why we support the @HarvardChanSPH and their youth summit on climate, equity and health. See how else we’re addressing this health crisis:
-
Biogen
@biogen
#tbt to when we first opened our Cambridge Community Lab 20 years ago, and committed to inspiring the next generation of STEM leaders. #caringdeeply
-
Biogen
@biogen
For the fifth year in a row, we’ve earned 100% on @Disabilityin's Disability Equality Index. We are dedicated to both inclusivity and accessibility for all our employees.
-
Biogen
@biogen
In 2021 we completed the first lifecycle assessment of our #biosimilars products to deliver on our goal to improve their carbon footprint.
-
Biogen
@biogen
One of the most promising developments in recent research has been the discovery of a biomarker prevalent among many devastating neurodegenerative diseases – neurofilament. Our Head of Fluid Biomarkers, Danielle Graham, Ph.D., sheds light on this perspective in STAT News.
-
Biogen
@biogen
More than 25 genes are linked to amyotrophic lateral sclerosis (#als), or motor neuron disease (#mnd). Gudjon, from Iceland, is living with ALS/MND and shares his thoughts on genetic counselling. #alsmndwithoutborders
-
Biogen
@biogen
Our employees have taken actions globally to increase awareness and acceptance of LGBTQ+ individuals, and to help foster inclusion within Biogen and our communities. Our aim is for everyone to bring their authentic selves to work – this #pridemonth and beyond.
-
Biogen
@biogen
Amyotrophic lateral sclerosis (#als), or motor neuron disease (#mnd), is a progressive disease that impacts the ability to move, speak, eat and eventually breathe. Orlando from Colombia celebrates life thanks to a strong support network. #alsmndwithoutborders
-
Biogen
@biogen
Our Biogen Digital Health team is hosting a symposium at the @EANeurology Congress covering machine learning (ML) in #neuroscience. Join us at #ean2022:
-
Biogen
@biogen
Join us tomorrow at the @EANeurology Congress, in-person or via live-stream for “Strategies in MS Care: New Therapies in Practice.” Learn more about real-world #multiplesclerosis (MS) clinical trials:
-
Biogen
@biogen
We look forward to sharing our latest #multiplesclerosis (MS) research at the hybrid @EANeurology Congress. Join us in-person at booth #504 or live-stream the meeting. View the #ean2022 program:
-
Biogen
@biogen
Producing #biosimilars requires strong expertise in high-quality and complex manufacturing #biologics #biosimilarmanufacturing
-
Biogen
@biogen
Armany is a Biogen Community Lab alum & @RedSoxFund scholar. To celebrate 20 years of #caringdeeply for the Community Lab and Foundation, he threw out the first pitch at a recent @RedSox game.
#community | #stem -
Biogen
@biogen
We are teaming up with @HappifyHealth to offer AI powered #digitalhealth resources to people with #multiplesclerosis (MS) – where they can engage with #neurologists, access mental health specialists, learn about treatment options, and connect with the #mscommunity. Read more:
-
Biogen
@biogen
This #worldalsday, we recognize that #als affects people in every corner of the world. Each year, there are approximately 140,000 new cases of ALS diagnosed worldwide. Learn more about how we aspire to improve the lives of people with ALS and those who care for them.
-
Biogen
@biogen
A diagnosis of amyotrophic lateral sclerosis (#als) or motor neuron disease (#mnd) is life changing for those with the condition and their loved ones. On Global ALS Awareness Day, Alper from Turkey reflects on coming to terms with the progressive condition. #alsmndwithoutborders
-
Biogen
@biogen
Nicole Murphy, Head of Pharmaceutical Operations & Technology, explains that most of a company’s environmental impact comes from its supply chain. In our quest to go fossil fuel free, we are engaging partnering with industry peers and suppliers to address ways to decarbonize.
-
Biogen
@biogen
We must continue to be guided by our belief in equality and racial justice. In observance of #juneteenth, we celebrate the contributions of Black and African Americans, and we reaffirm our commitment to being a positive force for change in our communities.
-
Biogen
@biogen
Thank you @CureSMA for offering valuable educational opportunities for people to learn more about #sma at the #smaconference2022. Hear from Kristen Fortino, Head of Biogen’s Rare Disease Franchise, as she reflects on the past few days:
-
Biogen
@biogen
We are inspired by the unique journeys of each person impacted by #sma. Caitlin, a woman living with SMA Type 1, shares her story and outlook on life:
#smaconference2022 #understandingsma -
Biogen
@biogen
We’re kicking off the 20th anniversary of the Biogen Foundation & Community Lab by cheering on Armany, a Community Lab alum & @RedSoxFund Scholar. He threw out the first pitch at tonight’s @RedSox game. Here's to 20 years of #caringdeeply!
-
Biogen
@biogen
We are in the midst of the family track for #smaconference2022. Hear from Kristen Fortino, Head of Biogen’s Rare Disease Franchise:
-
Biogen
@biogen
Nathan works full time and represents the U.S. on the National Power Soccer Team. He also lives with #sma. As the SMA community gathers this week at the #smaconference2022, Nathan encourages others living with a rare disease to feel empowered. #understandingsma @powersoccerusa
-
Biogen
@biogen
We understand there may be questions and misconceptions about #sma and its impact on people’s lives. Watch to learn more about living with SMA and get the facts:
#understandingsma #smaconference2022 -
Biogen
@biogen
We are presenting new data at this year’s #smaconference2022, including updates from our ongoing #sma studies aimed at advancing the science of SMA to help further inform the community. Learn more:
-
Biogen
@biogen
We look forward to reuniting in person with the #sma community this week at the @CureSMA #smaconference2022. As a presenting sponsor, we will share our latest research and host educational and social activities for attendees. Check out the conference program:
-
Biogen
@biogen
We are celebrating 20 years of serving our communities through the Biogen Foundation & Community Lab. We have strived to advance science education, improve health equity and address food insecurity in underserved communities.
-
Biogen
@biogen
Thank you to all the attendees at @mscare this year who showed us what they are grateful for by hanging a ribbon on our Gratitude Tree. We are grateful to serve the #multiplesclerosis community through pioneering science. #cmsc2022
-
Biogen reposted
NC Department of Labor
@NCDOL
On Thursday, Labor Commissioner Josh Dobson visited Biogen Drug Substance (DS) lab in Durham at the Research Triangle Park facility. Biogen DS was initially certified as a Carolina Star site in 2012. Thank you for going above and beyond to foster a safe work environment!
-
Biogen
@biogen
We invite all HCPs to join a Biogen-sponsored webinar to learn more about how the introduction of biosimilars may impact ophthalmological care, hosted by the Biosimilars Forum @USBiosimilars #ophthalmology
-
Biogen
@biogen
Our R&D team is advancing treatment discovery by leveraging a toolbox of modalities to target a disease. Hear from Anabella Villalobos, Biogen Head of Biotherapeutics and Medicinal Sciences about providing options to individuals living with neurological diseases:
-
Biogen
@biogen
Today we announced a collaboration with Alectos Therapeutics to develop and commercialize an investigational drug for the potential treatment of #parkinsonsdisease – a disease that affects approximately 10M people worldwide. Read here:
-
Biogen
@biogen
Biogen is studying #neurofilaments as potential biological markers in neurological diseases like #als. We believe biomarkers may offer an opportunity to measure stages of disease and potential clinical effects. Learn more about neurofilaments:
#encals -
Biogen
@biogen
Today, we will be at the 4th annual More About MS Patient Program that we are supporting at @mscare for people living with #multiplesclerosis, caregivers, or those interested in learning more. Join us in-person at #cmsc2022 or live-stream. Register to watch below.
-
Biogen
@biogen
#pridemonth is time to celebrate the #lgbtq+ community. We foster a workplace where everyone feels a sense of belonging. We’re proud of the progress our colleagues have made championing equality and inclusion around the world.
-
Biogen
@biogen
Biogen and Bio-Thera Solutions present new data from the Phase 3 comparative clinical trial on BIIB800, a biosimilar candidate, at the Annual European Congress of Rheumatology #eular2022.
-
Biogen
@biogen
We recognize the U.S. #mlb teams playing on the 2nd annual #lougehrigday to raise awareness of the devastating impacts of #als. When Noel was diagnosed, he didn’t know much about the disease beyond Lou Gehrig’s experience. Learn more about his journey with ALS.
-
Biogen
@biogen
Biogen is proud to sponsor the Educational Supporter Showcase at #cmsc2022. If you’re a health care professional at @mscare, join us tomorrow, June 3, at 12:15pm ET for expert presentations about relapsing #multiplesclerosis (MS).
-
Biogen
@biogen
We are pleased to announce that the first ophthalmology biosimilar in the U.S. market, is launching today
-
Biogen
@biogen
Biogen’s Biosimilars team shares Real World Evidence (RWE) during the #eular Congress to help inform healthcare decisions about biologic reference products and #biosimilars.
#biogen -
Biogen
@biogen
We have announced topline results of the Phase 3 SKYLARK Study of our investigational oral drug with @SageBiotech in women with #ppd. Read more.
-
Biogen
@biogen
Our development partner @SamsungBioepis will be presenting new #biosimilars data during the Annual European Congress of Rheumatology #eular2022
-
Biogen
@biogen
Educating patients about #biosimilars is important for providing an understanding of their efficacy and safety.
#biogen #patienteducation -
Biogen
@biogen
With the May 50K, we have an opportunity to help improve access to treatment, celebrate support networks and champion wellness for people living with #ms. Join our colleagues across the globe by walking, running, swimming or cycling 50 kilometers. #leaveyourlimitsbehind
-
Biogen
@biogen
Tracy was diagnosed with #multiplesclerosis (MS) at 25 years old, but she refused to let it define her. On #worldmsday, listen to Tracy’s story and see how she continues to pursue her passions.
This media couldn't be displayed. See it on the original post. -
Biogen
@biogen
We look forward to participating in next week’s @mscare (#cmsc2022) 2022 meeting, with many presentations showcasing innovative #multiplesclerosis (MS) research from our portfolio of therapies. Learn more about our commitment to MS:
-
Biogen
@biogen
We’re inspired by our colleagues who care deeply about serving humanity through science. Learn how we’re creating a healthier, more sustainable and equitable world. #esg #sustainability
-
Biogen
@biogen
This #lupusawarenessmonth, we are recognizing the millions of people who are affected by this autoimmune disease which can attack the skin, joints and internal organs.
-
Biogen
@biogen
Following an ALS diagnosis, the average life expectancy is 2-5 years. This #alsawarenessmonth, we honor those fighting this devastating disease and we take pride in partnering with advocacy groups around the world working to bring greater awareness to ALS.
-
Biogen
@biogen
Our colleagues’ hard work has advanced our climate, health and equity strategy. We’re proud to be recognized on @3BLMedia’s 100 Best Corporate Citizens list. #esg #environment #sustainability
-
Biogen
@biogen
Some people with #lupus may face barriers to care. We are advancing research to better understand the disease and why it may disproportionately affect some individuals. Learn more this #lupusawarenessmonth:
-
Biogen
@biogen
As a purpose-driven company, we seek ways to reinforce our commitment to climate, health and equity. Our Year in Review reports on our progress on these and other priorities to create a healthier, more equitable and sustainable world.
-
Biogen
@biogen
Every 90 minutes, someone is diagnosed with amyotrophic lateral sclerosis (#als) and 5-10% of cases are inherited from a family member. In some cases, ALS may be connected to a known gene mutation. Learn more about this disease during #alsawarenessmonth.
-
Biogen
@biogen
This week is #clinicaltrialsawarenessweek, and we support the efforts of @LupusResearch to diversify and expand clinical research in #lupus. Learn more about the #manyonecan campaign to raise awareness and help fund important research for those living with lupus.
-
Biogen
@biogen
Watch @mweissko’s presentation on findings from a meta-analysis funded by Biogen looking at the link between #airpollution and #dementia.
Harvard Chan NIEHS Center for Environmental Health
@hsphniehsctr
ICYMI: Center Director @mweissko gave a lecture on 'Air Pollution Effects on the Central Nervous System' at Collège de France @cdf1530 earlier this month #airpollution
📹Watch now:
www.college-de-france.fr/site/remy-slama/seminar-2022-04-… -
Biogen
@biogen
In most #als cases, the cause of the disease is unknown. But even if a person is the only known member of their family to be diagnosed with ALS, a genetic component may be involved. This #alsawarenessmonth, learn more about ALS science and research.
-
Biogen
@biogen
Today we acknowledge World IBD day. Learn more about Biogen’s commitment to raising awareness about inflammatory bowel diseases, such as Crohn’s disease and ulcerative colitis. #worldibdday #biosimilars #biogen
-
Biogen
@biogen
Lupus can impact many parts of the body, which means the disease can be hard to diagnose. One of our team members, Hazura, shares her personal journey living with lupus this #lupusawarenessmonth:
-
Biogen
@biogen
#leaveyourlimitsbehind and join us in The May 50K challenge. Walk, run, swim or cycle 50 kilometers to help raise awareness and champion wellness for people living with #ms.
-
Biogen
@biogen
Systemic #lupus accounts for approximately 70% of all cases of the disease. In approximately half of these cases, a major organ or tissue in the body, such as the heart, lungs, kidneys or brain will be affected. Learn more during #lupusawarenessmonth from @lupusorg:
-
Biogen
@biogen
Our Biogen colleagues welcomed @n_lorem and Founder and CEO @DrStanleyCrooke to discuss treatment access for ultra-rare diseases using #asos. We are proud to support and learn from organizations like these to create a better future for every patient. www.nlorem.org
-
Biogen
@biogen
In 2020, going virtual for the Community Lab meant going global. Over the past two years of the Biogen-@LemelsonMIT Biotech in Action program, we have reached 10,000 students in 19 countries. Alex Cameron, Community Lab Manager, discussed this and more on the @Labster podcast.
-
Biogen
@biogen
Today we announced a new collaboration with @MedRhythms to develop and commercialize a prescription digital therapeutic being investigated to potentially treat gait deficits in #multiplesclerosis – a disease that impacts over 2.8M people worldwide.
-
Biogen
@biogen
This May, Biogen is taking part in The May 50K challenge to raise awareness for the MS community! Our teams across the globe are challenging themselves to run, walk, swim or cycle 50 kilometers while raising funds to support international MS research. #leaveyourlimitsbehind
-
Biogen
@biogen
#biosimilars are medicines that are highly similar to currently available #biologic therapies known as originators.
-
Biogen
@biogen
Our Biosimilars team is excited to attend #arvo2022 . ARVO is a great chance to learn about the potential developments in #ophthalmology research. #hcps
-
Biogen reposted
Chirfi Guindo
@ChirfiG
.Biogen CMO Dr Radhakrishnan discusses #healthequity & #clinicaltrialdiversity at @NMQF Summit. Thx to CEO Dr Puckerein & team for bringing us together to discuss such important topics!
-
Biogen
@biogen
#dyk labs can use 3-10x more energy than a typical office building? In 2021, 14 Biogen labs participated in @My_Green_Lab to identify more #sustainable lab practices. We continue to #investinourplanet through our Healthy Climate, Healthy Lives initiative. #earthday
-
Biogen
@biogen
John Beaver, Head of Biomarkers at #biogen, discusses his passion for #neuroscience and how it has led him to where he is today:
-
Biogen
@biogen
The social and economic burden of #parkinsons is projected to grow as the population ages. Our aim is to develop therapies that may help impact people living with Parkinson’s and their caregivers. This #parkinsonsawarenessmonth, learn more:
-
Biogen
@biogen
Clement Sequeira is 1 of 1,000 employees using Biogen’s #sustainability benefits. Our fossil fuel free incentive program is part of our Healthy Climate, Healthy Lives program, helping employees make healthier, more climate-friendly choices in their homes.
-
Biogen
@biogen
We’re proud to sponsor the 10th Annual Hope on the Harbor, bringing together corporate and philanthropic leadership to support @alzheimersmanh. Learn more about this event to raise awareness and further our goal of a world without #alzheimers and other #dementias:
-
Biogen
@biogen
We're joining the @HRC and Freedom For All Americans (@freedom4allusa) in condemning anti-LGBTQ+ legislation and policies being introduced nationwide. We deeply value our LGBTQ+ team members and will continue making their safety a top priority, both inside and outside the office.
-
Biogen reposted
National Humanities Center
@NatlHumanities
What can research orgs, corporations, & NGOs do to ensure health resources are distributed equitably on a global scale? Leading experts will address the current challenges facing internationally focused work across sectors & industries. Register: nationalhumanitiescenter.org/crisis-of-caring-humanities-… #medhum
-
Biogen
@biogen
How we define value in Alzheimer’s has meaning on many levels. Hear from Chris Leibman, Head of Global Value & Access at Biogen, on the importance of making an impact at the earliest stages of Alzheimer’s disease:
-
Biogen reposted
Harvard Chan NIEHS Center for Environmental Health
@hsphniehsctr
@Biogen and @HSPHNIEHSCenter are conducting the most comprehensive systematic review and meta-analysis on the potential link between #airpollution and #dementia.
Member Elissa Wilker will present a paper at the #aanam conference in Seattle this week🧾
www.aan.com/events/annual-meeting/registration -
Biogen
@biogen
This #worldparkinsonsday, learn more about our ongoing research investigating multiple scientifically validated genetic pathways implicated in #parkinsons disease:
-
Biogen
@biogen
Health authorities and payers search for ways to balance bringing innovative drugs to areas of unmet need, while maintaining choice and access for patients and providers in more established diseases. Find out how #biosimilars can help.
#biogen #innovation -
Biogen
@biogen
Our presentations at #aanam include emerging research with the potential to reframe the treatment of diseases like #multiplesclerosis and #alzheimers. In fact, we’re using new technologies like biomarkers to innovate across neuroscience. Read more:
-
Biogen
@biogen
We’re one of @Newsweek's Most Responsible Companies and one of @BioSpace's Best Places to Work and we couldn’t be prouder of our team. Check out the full list:
#caredeeplyworkfearlessly -
Biogen
@biogen
Alzheimer’s disease contributes to 60-70% of dementia cases worldwide, with physiological, psychological and economic impacts on individuals, their families and society as a whole. Understanding the impact of the disease is a key piece of the Alzheimer’s puzzle. Learn more:
-
Biogen
@biogen
We know there may be questions and misconceptions about spinal muscular atrophy (#sma) and its impact on people’s lives. Watch to learn more and get the facts:
#understandingsma -
Biogen
@biogen
#alzheimers disease can be an isolating and intense experience for loved ones and people living with the disease. Hear journalist and patient advocate Greg O’Brien share how Alzheimer’s has affected him:
-
Biogen
@biogen
Research indicates that genetic factors may contribute to the development of the second most common neurodegenerative disease - #parkinsons disease. This #parkinsonsawarenessmonth, we recognize the millions of people living with Parkinson's worldwide.
-
Biogen
@biogen
#aanam: #alzheimers disease is a complex puzzle. Working to solve it means following the science, learning from those who came before us and listening to those living with the disease. Learn more:
-
Biogen
@biogen
Ivana Rubino, Head of Medical, Alzheimer’s Business Unit at Biogen, speaks to the valuable and important role that doctors play in a person’s journey with #alzheimers disease:
-
Biogen
@biogen
#aanam Spotlight: People living with neurological diseases inspire us and are the driving force at the core of our research. Read Mayu’s story of finding strength and hope after her #multiplesclerosis diagnosis:
-
Biogen
@biogen
#neuroscience News: Biogen is presenting new data at this year’s #aanam, with updates from across our portfolio of #multiplesclerosis therapies and emerging digital health research. Learn more:
-
Biogen
@biogen
#alzheimers and other #dementias have physical and psychological impact, not only for people living with the disease but also for their #caregivers, which can result in economic consequences for society at large. Learn more:
-
Biogen
@biogen
Thank you to all the women who paved the way so we could forge our own paths today. This #womenshistorymonth we honored #womeninscience by continuing our commitment to making #stem more accessible to girls and other underrepresented groups.
-
Biogen
@biogen
We’re looking forward to attending the #aanam 2022 annual meeting in person, starting tomorrow. Stay tuned to hear more about our latest work in #neuroscience.
-
Biogen
@biogen
An #alzheimers disease diagnosis comes with the awareness of the gradual loss of who a person once was, affecting not only them but those around them. For physicians it means preparing someone for what’s to come. Hear from the people impacted by Alzheimer’s:
-
Biogen
@biogen
In her latest article, Steffanie Bristol discusses the potential of #artificialintelligence and #machinelearning (AI/ML) in healthcare. Learn more:
#biogendigitalhealth -
Biogen
@biogen
We're proud to share this #healthequity in MS video that focuses on issues impacting members of underserved and underrepresented communities with #multiplesclerosis with @NerdyNeuroMD and Matt Winton, PhD, Head of US MS Franchise at Biogen. Watch here:
-
Biogen
@biogen
A #biosimilar is a biologic medicine that is highly similar to a branded reference product. Find out more:
-
Biogen
@biogen
Samantha Budd Haeberlein, SVP of the Neurodegeneration Development Unit at Biogen, discusses the need for clinical trials to address Alzheimer’s earlier in the patient journey. Watch now:
-
Biogen
@biogen
Tomorrow is the last day to apply to the Biogen Worldwide Medical PhD Fellowship. Apply today to prepare for a career in the pharmaceutical industry:
-
Biogen
@biogen
Today we submitted our final study protocol for our Phase 4 trial in Alzheimer’s Disease to the U.S. FDA for review and approval. Read the latest news here.
-
Biogen
@biogen
In the past 20 years, imaging has changed scientists’ ability to see inside the brains of people living with #alzheimers disease. Hear from John Beaver, head of Biomarkers at #biogen, about how these new technologies are advancing neuroscience:
-
Biogen
@biogen
Having successfully delivered complex originator #biologics for approximately 40 years, we have the experience and expertise needed to deliver #biosimilars of advanced biologics. Find out how we are carving out space for innovation with biosimilars:
-
Biogen
@biogen
Understanding the role of tau and amyloid proteins in #alzheimers is essential to development of potential treatment. We are in pursuit of answers. Learn more:
-
Biogen
@biogen
Fatta Nahab believes that digital technologies could play a crucial role in healthcare and in particular, clinical trials. Learn more in his newest article:
-
Biogen
@biogen
We are proud to have provided in-kind and financial support to this program.
UsAgainstAlzheimer's
@UsAgainstAlz
Every 60 seconds someone in the United States develops #alzheimers. It is one of the top 10 leading causes of death in the U.S. today, making early detection key. One step in that direction is by answering a few questions on mybrainguide.org #brainguide
-
Biogen
@biogen
The science, patient experience, and societal impact are all pieces of the #alzheimers disease puzzle – understanding each of them is the first step in the fight against the disease. Learn more about our approach:
-
Biogen
@biogen
The answer to yesterday’s poll is: 2,077. It is estimated that 24,924 new Americans are diagnosed with #multiplesclerosis (MS) each year. That's 2,077 people diagnosed every month on average. Learn more this #msawarenessmonth:
#msispersonal -
Biogen
@biogen
Some say that spinal muscular atrophy (#sma) affects the brain, causing people with the disease to have trouble remembering, learning new things & making decisions. What do you think? Watch to learn more about #understandingsma:
-
Biogen
@biogen
Ready to test your #multiplesclerosis (MS) knowledge this #msawarenessmonth? On average, how many new cases of MS are diagnosed in the U.S. each month?
-
Biogen reposted
NMQF
@NMQF
Today, @biogen's Maha Radhakrishnan, MD, & NMQF's Gary Puckrein, PhD, discussed the importance of real-world evidence (RWE) & issued a white paper highlighting how RWE can include historically underrepresented populations in randomized controlled trials.
ai-healthnet.com/national-minority-quality-forum-biogen-w… -
Biogen
@biogen
We are applying #greenchemistry principles to support sustainable drug development, reducing waste and minimizing the use of natural resources and energy. Learn more about our commitment to fight climate change and our Healthy Climate, Healthy Lives initiative:
-
Biogen reposted
NMQF
@NMQF
📢 Today at 12 p.m. ET:
Join NMQF President and CEO Gary A. Puckrein, PhD, Biogen's Maha Radhakrishnan, MD, and @MiaKeeys for an important discussion on using real-world data to foster #healthequity in research and care.
Register now. ⤵️
events.r20.constantcontact.com/register/eventReg?oeidk=a0… -
Biogen
@biogen
There may be questions about how an inherited disease like spinal muscular atrophy (#sma) could get passed down from parent to child. Learn more about the genetics of SMA. #understandingsma
-
Biogen
@biogen
We have been committed to advancing the understanding of #multiplesclerosis (MS) for more than 25 years, with a goal of helping to improve outcomes for those with this debilitating, heterogeneous disease. We stand with the MS community today and every day.
-
Biogen
@biogen
This week we recognize Brain Awareness Week, a global education initiative supporting public knowledge of the impact of brain science. Discover events and find more resources:
-
Biogen
@biogen
Data from our Phase 3 trials in early #alzheimersdisease are now published in the peer-reviewed journal @jpreventionalz1. Read our news release: investors.biogen.com/news-releases/news-release-details/b…
-
Biogen
@biogen
Congrats to the Muscular Dystrophy Association (#mda) for hosting a successful hybrid Clinical & Scientific Conference. We are committed to improving care for people with #neuromuscular diseases & enjoyed learning more about the latest research. @MDAorg
-
Biogen
@biogen
Don’t miss it: Today at #adpd2022 Samantha Budd Haeberlein, Head of Biogen’s Neurodegeneration Development Unit, will discuss pivotal advancements in #alzheimersdisease research. Read our news release.
-
Biogen
@biogen
It’s a common misconception that adults with spinal muscular atrophy (#sma) can’t be independent or live on their own. Watch to learn more about living with SMA & different levels of supportive care. #understandingsma
-
Biogen
@biogen
Welcome back, @foodforfreeorg! We are excited to see you serving the community again from our kitchen here at Biogen. We are proud to support the important work you are doing with the Heat-n-Eats program to combat food insecurity in the Greater Boston area.
-
Biogen
@biogen
We are currently accepting applications for the Biogen Worldwide Medical PhD Fellowship, an opportunity to explore different functional areas within the pharmaceutical industry. Apply by March 31:
-
Biogen
@biogen
We look forward to presenting new data in #alzheimersdisease at #adpd2022. Read more about the upcoming data presentations in our news release.
-
Biogen reposted
Hilarity for Charity (HFC)
@WeAreHFC
HFC's annual storytelling & photography contest, #humansofdementia, is back! Know a high school or college student? Invite them to tell their story for the chance to win cash prizes and more! Learn more about the contest at wearehfc.org/events/humans-of-dementia/!📸✍🏼
-
Biogen
@biogen
Research shows #biosimilars have similar safety and effectiveness as originator biologics and can offer a more cost-effective option, thereby contributing to lower healthcare costs and increasing patient access. #biogen #atnf
-
Biogen
@biogen
We’re headed to the Muscular Dystrophy Association (#mda) Clinical & Scientific Conference next week. We’re eager to share updates on our spinal muscular atrophy (#sma) research, host an educational forum & hear from the #neuromuscular community. View the @MDAorg schedule:
-
Biogen
@biogen
Black Americans are twice as likely as white Americans to have #alzheimers disease or another #dementia. Our Intuition Study aims to develop a better understanding of the overall brain health of people from all walks of life and backgrounds. Learn more:
-
Biogen
@biogen
#hcps #neurologists: Hope to see you at #adpd2022 next week. We’ll be sharing our latest research in #alzheimersdisease. Register today.
-
Biogen
@biogen
A survey of individuals living with #multiplesclerosis (MS) in the U.S. and Canada found MS-related disability to be twice as prevalent in Black patients than white patients. Learn how we are leveraging real-world health inequity insights to inform effective change:
-
Biogen
@biogen
Solomon Carter Fuller, a neurologist and the first U.S. psychiatrist of African descent, supported groundbreaking research on physically observable abnormalities in the brains of individuals with the disease that would later become known as #alzheimers. Read more:
-
Biogen
@biogen
Do you know a high school student interested in STEM? Someone who wants to learn from professionals at Biogen and @lemelsonMIT? Applications are now open for our free global Biogen-MIT Biotech in Action: Virtual Summer Lab. We look forward to meeting our future scientists.
-
Biogen
@biogen
Some people may think spinal muscular atrophy (#sma) is always a fatal disease. Advances in SMA screening and innovation aim to improve outcomes in those diagnosed early in life, with the more rapidly progressing types of SMA. Watch to learn about #understandingsma.
-
Biogen
@biogen
This #internationalwomensday, our colleagues stand in solidarity for gender equality. Every day we work to #breakthebias by sustaining a diverse and inclusive environment. #iwd2022
-
Biogen
@biogen
Some people may believe spinal muscular atrophy (#sma) is a disease that only occurs in infants and young kids. In fact, SMA can be diagnosed in teens, young adults and older adults. Watch to learn common misperceptions about SMA. #understandingsma
-
Biogen
@biogen
#alzheimers and #dementia awareness and education are critical in addressing the neurological disorders that disproportionately impact African Americans. Visit The National Brain Health Center for African Americans, a program of @thebalmingilead, to learn more:
-
Biogen
@biogen
We look forward to presenting at the Cowen 42nd Annual Health Care Conference. Watch the live webcast below:
-
Biogen
@biogen
Dr. Monica W. Parker highlights the importance of screening #alzheimers patients for comorbid conditions. She is a Family Physician, Geriatric Primary Care Provider and currently a Research Investigator with the Goizueta Alzheimer’s Disease Research Center @EmoryUniversity.
-
Biogen
@biogen
-
Biogen
@biogen
#digitalhealth has the potential to deepen our understanding and improve care for people living with neurological conditions. Shibeshih Belachew explores with @PoliticoEurope how bringing together #biology and #technology can improve understanding of neurological diseases.
-
Biogen
@biogen
Dr. Monica W. Parker (Research Investigator with the Goizueta Alzheimer’s Disease Research Center @EmoryUniversity) shares how multiple comorbidities can complicate the journey to an #alzheimers disease diagnosis.
-
Biogen
@biogen
Each year, Biogen awards two “Golden Tickets” to local biotech start-up companies to take up residency in @LabCentral’s Kendall Square facilities in Cambridge for up to one year. Congratulations to this year’s winners, Bolden Therapeutics and Accure Health.
-
Biogen reposted
Cure SMA
@CureSMA
Congratulations to New Jersey AND Idaho for officially implementing SMA newborn screening! As of this morning, 91% of babies born in the U.S. are now being screened for SMA. Thank you to all of our advocates who made this milestone possible. 💜🧡
www.curesma.org/newborn-screening-for-sma/ -
Biogen
@biogen
“The object that signifies my life #beyondsma is the statue of Justitia. As Justitia is the symbol of justice, she best represents my ambition for a world with more fairness and equal opportunities.” - Tina, #sma Type 2 and fighting for equality. #rarediseaseday
-
Biogen
@biogen
Dr. Monica W. Parker, Research Investigator with the Goizueta Alzheimer’s Disease Research Center @EmoryUniversity, unpacks social risk factors faced by unrepresented and underserved #alzheimers patients.
-
Biogen
@biogen
We thank the researchers, clinicians and @ACTRIMS for the 2022 Forum and want to recognize the thought-provoking presentations about important advancements in biomarkers for #multiplesclerosis. This research can potentially help drive the ongoing development of MS treatments.
-
Biogen
@biogen
Biogen’s portfolio of anti-TNF #biosimilars generated an estimated €2.6 billion in savings for European healthcare systems in 2021.
-
Biogen
@biogen
The #raredisease community is comprised of more than 300 million people worldwide. Every day we aspire to improve the lives of those living with a rare disease.
#rarediseaseday -
Biogen
@biogen
It’s #rarediseaseday and we are celebrating the lives of people with spinal muscular atrophy (#sma). Hear from Jakob, a true team player, as he describes his experience living with a rare genetic disease:
-
Biogen
@biogen
Today, Biogen’s James R. Williams was featured in a sponsored @BostonGlobe article, discussing the future of #digitalhealth and providing an overview of our virtual research study, Intuition.
-
Biogen
@biogen
Considering whether to get tested for genetic amyotrophic lateral sclerosis (#als) can trigger a series of complex emotions. Learn how Jeremy turned his apprehension into motivation to advocate for more education surrounding genetic ALS:
#rarediseaseday -
Biogen
@biogen
February 28th is #rarediseaseday, a time to recognize the strength and resiliency of the rare disease community, including those living with spinal muscular atrophy (#sma). Learn more:
-
Biogen
@biogen
“Comorbidities are common among individuals living with #alzheimers disease and related dementias” explains Dr. Monica W. Parker, Research Investigator with the Goizueta Alzheimer’s Disease Research Center @EmoryUniversity. Learn more:
-
Biogen
@biogen
#angelmansyndrome (AS) is a rare genetic disorder that causes recurrent seizures & behavioral symptoms in children. This #rarediseaseday, we reaffirm our commitment to advancing research for people living with rare diseases worldwide.
-
Biogen
@biogen
As #rarediseaseday approaches on February 28th, we remain committed to supporting the #raredisease community by continuing our research and development in support of people affected.
-
Biogen
@biogen
The @alzassociation is working to address disparities in care for Black and African Americans living with #alzheimers or another #dementia by providing education, raising funds, and supporting advocacy. Learn more about #healthequity and how to make a difference:
-
Biogen
@biogen
We are excited to participate in the upcoming @ACTRIMS 2022 Forum, with a focus on Biomarkers in #multiplesclerosis. Highlights will include important advancements in biomarker science and improved technology for measuring biomarkers in MS. Learn more on #actrims below:
-
Biogen
@biogen
Tailored education around #alzheimers is a critical component in addressing the disease’s disproportionate impact on people of color, including Black Americans. Visit BrainGuide™ for #brainhealth resources to empower and educate families and communities:
-
Biogen
@biogen
On #nationalcaregiversday we honor all #caregivers – those caring for people with neurological and other diseases and those caring for family and loved ones. We support our employees who serve in caregiving roles with dedicated time off and wellbeing support. Learn more:
-
Biogen reposted
Lupus Foundation of America
@LupusOrg
We’re excited to introduce Strategies to Embrace Living with Lupus Fearlessly (SELF), our new online self-management program for adults living with #lupus.
SELF is free and full of useful tools, tips and support to help you better manage lupus. -
Biogen
@biogen
We are proud to be a corporate advisory board member for the @Child_Neurology Foundation (CNF). CNF is an advocacy organization that serves to connect individuals within the child neurology community to support those navigating a neurological disease.
-
Biogen
@biogen
When Kamaria's mother, Mary, was diagnosed with early-onset #alzheimers disease, she found a network of support in her extended family. Learn more about her story:
-
Biogen
@biogen
Biogen UK has been ranked in @GPTW_UK ’s 2022 #ukbestworkplacesforwellbeing. Thank you to our Employee Resource Networks and all of our employees for nurturing Biogen's culture
-
Biogen
@biogen
To understand patients, we must understand the #diverse socioeconomic and individual factors that impact health outcomes. Read about our collaboration with @TuftsCSDD that investigated ways to help improve a fundamental step in healthcare: #clinicaltrials:
#blackhistorymonth -
Biogen
@biogen
Through our #biosimilars Unit we support people living with inflammatory bowel diseases (#ibd) along their journey and today we are joining the #ecco2022 conference to be a part of the conversation around IBD care. Join us if you want to learn more. #hcps only
-
Biogen
@biogen
Today, in partnership with @SageBiotech, we announced positive results from the Phase 3 CORAL Study in patients with major depressive disorder (#mdd). Read the full release:
-
Biogen
@biogen
Tomorrow’s virtual session will provide information about our Worldwide Medical PhD Fellowship, potential careers in medical affairs, and navigating a transition to industry. To RSVP, please fill out this form:
-
Biogen
@biogen
Join today’s live event hosted by @Euronews as they bring together a panel of experts to discuss innovations in #rarediseases and the battle for progress.
#rarediseaseday | #sma | #icare4rare | #als -
Biogen
@biogen
“I do believe that my diagnosis was delayed simply because as a young, Black woman, I didn’t fit the mold of the typical MS patient.” Lauren’s story depicts the impact of racial and ethnic underrepresentation. Read about our efforts to address the issue of #healthequity:
-
Biogen
@biogen
On International Women & Girls in Science Day, we’re spotlighting Dr. Amanda Marvelle and how she inspires girls to explore careers in #stem. Learn more about the Community Lab.
#womeninscience -
Biogen
@biogen
Dr. Verneda Hawkins, Associate Director for U.S. Field Medical Excellence at Biogen, highlights the role of resilience in the face of adversity throughout her career journey. Learn how Dr. Hawkins hopes to inspire future generations:
-
Biogen
@biogen
Pioneering neuroscience and driving innovation comes from a truly diverse workforce. Our partnership with #hbcus and student internship program helps drive our efforts to ensure our future leaders come from all backgrounds. Hear more from our past interns:
This media couldn't be displayed. See it on the original post. -
Biogen
@biogen
Chris Henderson, Head of Research, shares how the understanding of one neurological disease could be applied to others, due to connections between them.
-
Biogen
@biogen
Murray Gillies, General Manager of Healthcare Professional Solutions at Biogen Digital Health, highlights three ways in which digital tools can help address neurologists' unmet needs. Read here:
-
Biogen
@biogen
Biogen’s Alazar Ayele will moderate a Citizen Schools student panel discussion on developing diverse STEM networks for social mobility. Register to attend:
-
Biogen
@biogen
Join us for an informational session about our two-year Worldwide Medical PhD Fellowship. To RSVP and gain an inside perspective on a potential career in industry, please complete this form by February 15:
-
Biogen
@biogen
Today, we announced an agreement with @XbraneBiopharma AB to commercialize & license a proposed biosimilar with the potential to add another option for patients with rheumatoid arthritis.
-
Biogen
@biogen
Congratulations to Ginger Gregory, our Chief Human Resources Officer, named one of the Top Industry Leaders in 2021 by @LifeSciVoice!
-
Biogen
@biogen
As part of our long-standing anti-CD20 collaboration with @Genentech, today we announced an option to participate in the development and commercialization of a late-stage bispecific antibody. Read here:
-
Biogen
@biogen
Caring deeply for the communities we serve is at the core of our culture. Global employees were challenged to log 10,000 hours of #volunteer work. Thank you to all who gave back.
-
Biogen
@biogen
Project #alzheimers Value Europe (PAVE), funded by Biogen and other stakeholders, was established to develop new research and inform the value assessment of, access to, and funding for, emerging Alzheimer’s innovations in Europe. Learn more:
-
Biogen
@biogen
Today we announced additional details for our Phase 4 #alzheimersdisease trial, ENVISION, including an ambitious diversity enrollment goal. Read more.
-
Biogen
@biogen
Alzheimer’s disease (#ad) is a growing global health challenge affecting those living with the disease and their families. #wewontrest until we build better education on the importance of #brainhealth @EFPIA
-
Biogen
@biogen
The @WBCSD’s #healthypeoplehealthybiz project understands business plays a critical role in realizing a healthier society. We contributed to the latest report: How can companies create a culture of health and wellbeing at the workplace?
-
Biogen
@biogen
#biosimilars have the potential to significantly drive down global spending over the next 5 years, improving healthcare savings and #patientaccess to important treatment options.
-
Biogen
@biogen
Dementia is not a normal part of aging. Diagnosing #alzheimers disease during its initial stages can provide medical, social and emotional benefits for patients and their caregivers. #wewontrest until our innovative research helps those impacted by Alzheimer’s disease @EFPIA
-
Biogen
@biogen
We’re proud to support @EFPIA on the #wewontrest campaign. Alzheimer’s disease is one of Europe’s largest public health crises. We won’t rest until we help to improve the lives of patients through innovation. #alzheimers
-
Biogen
@biogen
Applications are open for the Biogen Worldwide Medical PhD Fellowship, providing recent doctoral graduates with a hands-on introduction to a career in medical affairs. Apply by March 31 for an opportunity to learn the ins and outs of the pharmaceutical industry:
-
Biogen
@biogen
The answer to yesterday’s #knowyourbrainscience question is myelin, which covers and protects axons in the brain. Learn more about brain health:
-
Biogen
@biogen
We’re proud to be on the @corporateknight #global100. Our focus on health equity and programs like Healthy Climate, Healthy Lives helps advance a shared vision of a healthier, more inclusive and sustainable future.
-
Biogen
@biogen
#knowyourbrainscience trivia: What covers and protects axons in the brain?
-
Biogen
@biogen
Congratulations to the European Alliance for Newborn Screening in Spinal Muscular Atrophy and @SMAEurope for being named the winner of the @EURORDIS #blackpearlawards for Patient Engagement 2022. Biogen is proud to support the Alliance and its important work.
-
Biogen
@biogen
Older Black Americans are disproportionally more likely to develop Alzheimer’s disease and to have missed diagnoses compared to older non-Hispanic white Americans. Biogen is committed to equitable access and increased representation of underserved populations in clinical trials.
-
Biogen
@biogen
In communities of color, difficulties finding a specialist healthcare provider can be a barrier for timely Alzheimer’s diagnosis and quality care. Visit ‘It’s Time’ to learn more and find resources, including a specialist locator that may help families access the care they need:
-
Biogen
@biogen
Dr. Martin Luther King Jr. left a mission empowering people to advance a more just and equitable world. We at Biogen recognize the role we play to champion the power of diversity and to foster a shared vision of a more inclusive future.
-
Biogen
@biogen
Last week we announced an agreement with @ionispharma to develop and commercialize BIIB115, an investigational antisense oglionucleotide (ASO) drug for potential SMA treatment. Learn more about our goal of transforming the treatment of neurological diseases around the world.
-
Biogen
@biogen
A Coverage with Evidence Development policy by CMS can have serious ramifications for all patients, including deepening inequities for those already underserved. Learn more about Medicare’s potential impact on people living with #alzheimersdisease:
-
Biogen
@biogen
The answer to yesterday’s #knowyourbrainscience question is the blood-brain barrier. Learn more about brain health:
-
Biogen
@biogen
Restrictive Medicare coverage policies can have serious ramifications for patients – including delaying patient access to treatment and creating further health inequities for underserved patients. Read our statement regarding CMS’s draft National Coverage Decision.
-
Biogen
@biogen
We are honored to be recognized as a #just100 leader and one of #americasmostjust Companies by @justcapital_ and @CNBC. Thank you to our colleagues for making this possible!
-
Biogen
@biogen
#knowyourbrainscience trivia: What prevents most drugs from getting to the brain from the blood?
-
Biogen
@biogen
Over the past 5 years we’ve added 22 new clinical programs to strengthen our pipeline across therapeutics areas, including #multiplesclerosis, #depression, #stroke, #parkinsons and more. Watch our presentation at the @JPMorgan 40th Annual Healthcare Conference (#jpmhc22):
-
Biogen
@biogen
We are pleased to announce that we are an inaugural corporate participant in @JetBlue’s Sustainable Travel Partners program, aligning with our commitment to create a more sustainable world. Learn more about the new #sustainability program:
-
Biogen
@biogen
The answer to yesterday’s #knowyourbrainscience question is #parkinsonsdisease. Learn more about brain health:
-
Biogen
@biogen
#knowyourbrainscience trivia: Loss of nerve cells in the part of the brain called substantia nigra is associated with which neurological disease?
-
Biogen
@biogen
#happynewyear from Biogen! We look forward to another year focused on the patients we serve and the communities we support. We wish everyone a happy and healthy 2022.
-
Biogen
@biogen
This year, we shared data and important news updates that showcase our achievements across neuroscience and corporate responsibility. Visit our newsroom for our 2021 Biogen Highlights:
-
Biogen
@biogen
During our 2021 R&D Day, we featured presentations on our diversified portfolio across disease areas and therapeutic modalities, which will guide our path forward in 2022 and beyond. View the full webcast to learn more:
-
Biogen
@biogen
This year we shared stories of patients' remarkable journeys and our scientists' unwavering commitment and vision. Each of them is a reminder and an inspiration as we aim to improve patient lives in 2022 and beyond. Explore Our Stories:
-
Biogen
@biogen
Some people may think spinal muscular atrophy (#sma) is always a fatal disease. Advances in SMA screening and innovation aim to improve outcomes in those diagnosed early in life, with the more rapidly progressing types of SMA. Watch to learn about #understandingsma.
-
Biogen
@biogen
Did you know that biologics account for >40% of total medicines spending in the US? The further development and approval of #biosimilars medicines represents a significant opportunity for US patients, healthcare professionals, and the healthcare system.
-
Biogen
@biogen
Some people may believe spinal muscular atrophy (#sma) is a disease that only occurs in infants and young kids. In fact, SMA can be diagnosed in teens, young adults and older adults. Watch to learn common misperceptions about SMA. #understandingsma
-
Biogen
@biogen
Al Sandrock, Head of R&D, led the advancement of many transformative therapies for serious neurological conditions during his 23 years at Biogen. He reflects on his time here and the scientific rigor and focus on patients that will continue to be ingrained in our culture:
This media couldn't be displayed. See it on the original post. -
Biogen
@biogen
Our leadership and expertise in anti-TNF biosimilars supports European healthcare systems by expanding access to cost-effective treatment. Learn more about biosimilars at Biogen:
-
Biogen
@biogen
We support the recent resolution adopted by the General Assembly of the United Nations, which recognizes the unique needs of those living with rare diseases. Join us in celebrating this first-of-its-kind #resolution4rare:
-
Biogen
@biogen
Taliyah Townsend, a former Biogen intern, is part of this campaign celebrating inspirational students at HBCUs who are more than just athletes. At Biogen we work with HBCUs to offer internships with the aim of building a diverse STEM pipeline. Congrats Taliyah!
Nike.com
@nikestore
Meet #yardrunners 2021: former student-athletes turned pharmacists, entertainers, engineers, entrepreneurs, and the world’s next leaders coming out of Historically Black Colleges and Universities.
The 2021 #yardrunners Collection is available now.
go.nike.com/aUzO8E-Om2V -
Biogen
@biogen
Increasing the understanding and awareness of #biosimilars may provide an opportunity to drive down costs and expand #patientaccess to #biosimilar therapies. Read the latest white paper from @SamsungBioepis about key strategies to improving robust #biosimilaradoption:
-
Biogen
@biogen
Biomarker technologies are transforming the field of #neuroscience by allowing scientists and physicians to look into the brain of living patients and directly measure brain pathologies. Learn more:
-
Biogen
@biogen
“Mistrust of the healthcare system is a huge barrier to care among underserved caregivers and patients.” – Dr. Gibson of @uamshealth and @UAMSaging provides tips for healthcare providers engaging with the caregivers of typically underserved #alzheimers populations:
-
Biogen
@biogen
As electric vehicles (EV) become the new normal, we need a robust charging infrastructure. We are proud signatories of the #ev100 and #zevcommunity public EV fast charging principles for North America. @climategroup
#ev | #healthyclimate -
Biogen
@biogen
We understand #alzheimers to be a continuum that begins prior to symptoms, indicating a decline in cognitive function. Early detection and diagnosis is critical to advancing our understanding of the disease. Learn more about Biogen's commitment to the fight against Alzheimer's:
-
Biogen
@biogen
We are working to address the disproportionate impact of #alzheimers in certain racial and ethnic communities. A pivotal step in understanding this disparity is increased awareness and education.
UsAgainstAlzheimer's
@UsAgainstAlz
"People of color, but particularly women of color, are in the crosshairs of our nation’s dementia crisis."
UsA2's @jason_r_DC spoke with @washingtonpost about the need for #publichealth investment in a response to #dementia & #brainhealthequity. www.washingtonpost.com/wellness/2021/12/09/black-and-lati… -
Biogen
@biogen
Evidence continues to suggest that #alzheimers disproportionately affects certain racial and ethnic communities. Discover some of the factors that are driving these disparities in our article featured in @afronews:
-
Biogen
@biogen
#biomarker measurement technologies are unlocking a window to the brain. John Beaver, Biogen’s Head of Biomarkers, discusses how these technologies are driving a resurgence in #neuroscience drug development. Learn more:
-
Biogen
@biogen
Learn more about how different digital ptions like #telehealth can connect people, doctors and caregivers in new ways in this new article by Georgia Mitsi, General Manager of #mentalhealth & VR Solutions at #biogendigitalhealth.
#digitalhealth #digitalmedicine #neuroscience -
Biogen
@biogen
Honored to receive a Clean Energy Champion Award from @chambersinnov8 and @CCE_NC for our plans to reach 100% renewable energy by 2040. We will achieve this goal by working diligently with our suppliers to meet each milestone along the way.
#healthyclimate | #cleanenergy -
Biogen
@biogen
We are providing an update on our Phase 4 confirmatory study in Alzheimer’s disease. Read our latest news.
-
Biogen
@biogen
Today we announced a new collaboration with @TheraPanacea to advance personalized digital medicine in neuroscience using machine learning and AI. Read more:
#biogendigitalhealth -
Biogen
@biogen
Dr. Regina Gibson, Sr. Nurse Educator @uamshealth and @UAMSaging, shares her personal story of navigating the challenging yet rewarding experience of caregiving for family members with #alzheimers disease:
-
Biogen
@biogen
Irene Kanter Schlifke, General Manager of Patient Solutions at #biogen Digital Health, explains her commitment to co-creating patient solutions. Learn more:
#digitalhealth #digitalmedicine #neuroscience -
Biogen
@biogen
This year at the @ACNPorg Congress, we presented new analyses from the LANDSCAPE clinical development program for #mdd in partnership with @SageBiotech. For details, read the full press release:
#acnp2021 -
Biogen
@biogen
“Alzheimer’s disease can feel like something families and caregivers have to hide.” – Dr. Regina Gibson, Sr. Nurse Educator @uamshealth and @UAMSaging, shares her experience working with underrepresented and underserved caregivers of patients with #alzheimers disease:
-
Biogen
@biogen
This International Volunteer Day we recognize Inge Havermans, one of our employees who has a passion for volunteering and #caringdeeply. Learn more about our dedication to giving back:
#ivd2021 -
Biogen
@biogen
We were proud to sponsor and participate in this year’s @MassWomen conference, which provides forums for development, networking and inspiration from female leaders. Learn more:
#masswomen #womeninstem -
Biogen
@biogen
We’re proud to be a leader in @united’s Eco-Skies Alliance program to collectively contribute toward the purchase of sustainable aviation fuel. Learn more about the program and our commitment:
United Airlines
@united
Today, United will be the first in aviation history to fly a passenger flight using 100% sustainable aviation fuel (SAF).
This flight will serve as a turning point in the industry's effort to combat climate change. -
Biogen
@biogen
We recently published our 2021 #diversity, Equity & Inclusion Report and are dedicated to creating a healthier, more sustainable and more equitable world. Learn more about our #dei commitments here:
-
Biogen
@biogen
We scored 100% on the Disability Equality Index. Now Biogen CEO Michel Vounatsos signed the @DisabilityIN’s #ceoletter on #disabilityinclusion, further committing to an accessible, inclusive workplace for all. #areyouin #idpwd Learn more:
-
Biogen
@biogen
Junghae Suh, Head of the Gene Therapy Accelerator Unit, shared updates in gene therapy for neuroscience during Biogen’s Investor R&D Day in September. View Junghae’s presentation and others:
-
Biogen
@biogen
Congratulations to Johanna Jobin, Biogen’s Head of Global Corporate Reputation and Responsibility, named one of the Top 25 Innovators in the Americas by @Provoke_Media! Learn more: www.provokemedia.com/ranking-and-data/innovator-25/innova…
#innovator25 | #climateaction | #diversity | #healthequity -
Biogen
@biogen
Today, in partnership with @SageBiotech, we announced interim data from the open-label Phase 3 SHORELINE Study designed to follow patients with #mdd over the course of one year. Learn more here:
-
Biogen
@biogen
We are privileged to help provide support to our communities and friends globally this #givingtuesday. Join us in recognizing this day of generosity and learn more about our mission to care deeply:
-
Biogen
@biogen
Ranked in the top 1% of researchers in the field of #neuroscience and behavior, Dominic Walsh heads our Neurodegeneration Research Unit. Hear more about his unrelenting passion and pursuit of discovery in #alzheimers disease:
#nationalalzheimersawarenessmonth #everymemorycounts -
Biogen
@biogen
The answer to yesterday’s Know Your Brain Science question is All of the above. Learn more during #nationalalzheimersawarenessmonth:
-
Biogen
@biogen
We are proud to sponsor a symposium at the 31st @AlzheimerEurope Conference, featuring a discussion on how the Be Brain Powerful campaign helped to make brain health a priority on the public agenda. Register here:
#31aec #alzheimers -
Biogen
@biogen
Dominic Walsh, Head of Biogen’s Neurodegeneration Research Unit, reflects on his path to finding his passion in #alzheimers research and what motivates him to continue in the pursuit of discovery. Watch his full interview:
#nationalalzheimersawarenessmonth #everymemorycounts -
Biogen
@biogen
No two people living with #multiplesclerosis (MS) share the same story, including the impact of their caregiver(s). We are proud to celebrate #nationalfamilycaregiversmonth and acknowledge these individuals as a #caregiverand so much more. Learn more with @CaregiverAction
-
Biogen
@biogen
Today’s #nationalalzheimersawarenessmonth #knowyourbrainscience Question: Which of the following is a risk factor for Alzheimer’s disease?
-
Biogen
@biogen
The answer to yesterday’s #knowyourbrainscience question is 60-70%. Learn more during #nationalalzheimersawarenessmonth: www.biogen.com/en_us/alzheimers-center.html?cid=osm-twtr-…
-
Biogen
@biogen
Today’s #nationalalzheimersawarenessmonth #knowyourbrainscience Question: Alzheimer's disease is the most common form of dementia. What percentage of dementia cases are Alzheimer’s disease?
-
Biogen
@biogen
Chris Henderson, Head of Research, discussed our vision for building a pipeline of the future during Investor R&D Day. View all of the presentations from September’s Investor R&D Day:
-
Biogen
@biogen
As a founding member of the @Davos Alzheimer’s Collaborative (DAC), we support finding innovative solutions for #alzheimers. DAC is seeking grant applications from healthcare system innovators to drive earlier detection and increase cognitive assessment rates. Apply by Dec. 1:
-
Biogen
@biogen
The answer to yesterday’s #knowyourbrainscience question is #alzheimersdisease. Learn more during #nationalalzheimersawarenessmonth: www.biogen.com/en_us/alzheimers-center.html?cid=osm-twtr-…
-
Biogen
@biogen
Last week CEO Michel Vounatsos and North Carolina Secretary of Commerce Machelle Baker Sanders attended the groundbreaking on a #genetherapy #manufacturing facility at our #rtp campus. Learn more about this expansion to our existing operations:
-
Biogen
@biogen
Today’s #nationalalzheimersawarenessmonth #knowyourbrainscience Question: In 1906, which disease was first described as “a peculiar severe disease process of the cerebral cortex” during the 37th Meeting of South-West German Psychiatrists in Tübingen?
-
Biogen
@biogen
Spinal muscular atrophy (#sma) caregivers do so much for their loved ones. However, taking care of themselves is just as important. This #nationalfamilycaregiversmonth, we are reminded that they are each a #caregiverand so much more. Learn more with @CaregiverAction
-
Biogen
@biogen
The toll #alzheimers disease takes on patients and their loved ones is devastating. We thank journalist and patient advocate Greg O’Brien for reflecting candidly on his experience to recognize that #everymemorycounts this #alzheimersawarenessmonth. Watch now:
-
Biogen
@biogen
“Cultural humility encourages us to learn from our patients and the communities that we work with.” Dr. Miravalle, Associate Professor of Neurology @CUAnschutz, shares practical ways to improve cultural competency in clinical practice.
-
Biogen
@biogen
“Speaking Spanish allowed me to uncover mental health struggles such as depression & anxiety that may be contributing to the patient’s cognitive impairment.” Listen to @CUAnschutz Associate Professor of Neurology, Dr. Augusto Miravalle’s perspective on culturally competent care:
-
Biogen
@biogen
Dr. Augusto Miravalle, Associate Professor of Neurology @CUAnschutz, joins us in the RoAD Show to share what it means to build cultural competency in his neurology and #alzheimers disease practice.
-
Biogen
@biogen
The answer to yesterday’s #knowyourbrainscience question is Auguste Deter. Auguste was diagnosed in 1906 by Dr. Alois Alzheimer. Learn more this #nationalalzheimersawarenessmonth: www.biogen.com/en_us/alzheimers-center.html?cid=osm-twtr-…
-
Biogen
@biogen
Today’s #nationalalzheimersawarenessmonth #knowyourbrainscience Question: Who is the first known Alzheimer’s disease patient?
-
Biogen
@biogen
The answer to yesterday’s #knowyourbrainscience question is #alzheimersdisease. Learn more during #nationalalzheimersawarenessmonth: www.biogen.com/en_us/alzheimers-center.html?cid=osm-twtr-…
-
Biogen
@biogen
This #nationalalzheimersawarenessmonth, we are sharing disease knowledge with #knowyourbrainscience trivia. First question: Abnormal accumulation of Amyloid and Tau proteins are considered the pathological hallmarks of which neurological disease?
-
Biogen
@biogen
We were proud to sponsor @thebalmingilead Healthy Churches #hc2030 Conference, featuring discussions about the impact of #alzheimers on the African American community and the importance of early diagnosis. Learn more:
-
Biogen
@biogen
We are proud to be recognized by the @USCCFoundation as a #citizens2021 Awards finalist and winner of the Best #sustainability Program. Learn more about the purpose-driven businesses selected for their leadership in solving world challenges:
-
Biogen
@biogen
Family, neighbor, spouse, partner - each person caring for a loved one living with #alzheimers is a #caregiverand so much more. We are proud to acknowledge the role of caregivers for the Alzheimer’s community this #nationalfamilycaregiversmonth. Learn more with @CaregiverAction
-
Biogen
@biogen
We are proud to sponsor the next @womensalz summit during #alzheimersawarenessmonth, featuring journalist Maria Shriver and other leading #alzheimers experts as they discuss the importance of inclusivity in clinical trials. Register for the free event:
-
Biogen
@biogen
Update on Alzheimer’s Regulatory Review process in the European Union: investors.biogen.com/news-releases/news-release-details/u…
-
Biogen
@biogen
We are honored to be included in the @SPGlobal #djsi World Index for the 9th consecutive year, an industry record, for our enduring leadership and transparency in #environmental, social and governance (#esg) issues. Read about our #sustainability efforts:
-
Biogen
@biogen
We are pleased to announce that the European Commission has granted marketing authorization for one of our #multiplesclerosis treatments. Read more:
-
Biogen
@biogen
Al Sandrock, Head of R&D, will retire next month. “Al has dedicated his life to helping patients and is one of the most recognized drug developers of this generation,” says CEO Michel Vounatsos. We thank Al for his tremendous contributions to patients throughout his career.
-
Biogen
@biogen
Shibeshih Belachew, Vice President, Biogen Digital Health Sciences, will join an expert panel at #lausanneviii to discuss how digital health initiatives, such as our Intuition Study, are critical to the future of #alzheimers research. Register now:
-
Biogen
@biogen
HCPs: Miss out on #ctad21 last week? It’s not too late – visit the #ctad21 website to see the latest #alzheimersdisease research presented at this year’s meeting. Learn more:
-
Biogen
@biogen
Wanda Castro-Borrero’s passion for #healthequity is rooted in her personal experience and finding her voice. She hopes to provide the same support to those facing disproportionate health challenges. Learn more:
-
Biogen
@biogen
Today we shared ground-breaking new data at #ctad21 from our ongoing research efforts in #alzheimersdisease. Read our news release:
-
Biogen
@biogen
#hcps #neurologists: Join us today at 5:10 PM ET for a late-breaker presentation and panel discussion about new data involving the underlying pathologies in #alzheimersdisease at #ctad21. Register here:
-
Biogen
@biogen
During September’s Investor R&D Day, Nathalie Franchimont, Head of MS & Immunology Development, shed light on Biogen’s efforts in immunology. View all of the presentations from Investor R&D Day:
-
Biogen
@biogen
#hcps #neurologists: Dr. Sharon Cohen from @Toronto_Memory presented new data from an ongoing, large-scale trial in #alzheimersdisease. Tune into the presentation at #ctad21:
-
Biogen
@biogen
#alzheimersdisease is a growing public health crisis, with thousands of patients per day progressing to more advanced stages. Healthcare professionals: Learn more from our poster presentation at #ctad21: www.ctad-alzheimer.com
-
Biogen
@biogen
We value and proudly support our military veteran team members and their families. #veterans bring a strong commitment to community as we strive to transform the standard of care for patients in areas of unmet need. We honor all the veterans who have served. #veteransday
-
Biogen
@biogen
For 100+ years scientists have been working to understand the role of amyloid beta & tau proteins in #alzheimers. Hear from Dominic Walsh about his efforts to gain new insights into the brain & bring answers to those with Alzheimer’s.
#everymemorycounts #ctad2021 -
Biogen
@biogen
Improving #healthequity and eliminating barriers that contribute to the underrepresentation of certain populations in clinical trials is an important goal for us. Learn about our research to identify and address these barriers in #lupus, presented at #acr21.
-
Biogen
@biogen
In this piece, James R. Williams, PhD, looks at #digitalbiomarkers and passive monitoring technologies which may aid in empowering people living with neurodegenerative diseases.
#biogendigitalhealth #digitalhealth #digitalmedicine #neuroscience -
Biogen
@biogen
We are excited to be at #ctad21 discussing our new #alzheimersdisease data with the scientific community. Healthcare professionals can learn more and register to attend here:
-
Biogen
@biogen
#climatechange is everyone's business. Join us during #cop26 for a panel hosted with UN @globalcompact to discuss the latest science around #climate and its impact on human health – particularly for the most vulnerable. Register here to watch live: hopin.com/events/business-ambition-for-climate-action
-
Biogen
@biogen
As part of our celebration of 10 years of our Caring Deeply™ initiative, our team in Raleigh, North Carolina helped prepare food, sort clothing, and clean facilities at @OakCityCares, a nonprofit that serves the local homeless population.
-
Biogen
@biogen
We aim to support a more healthy, equitable and sustainable world through corporate giving, #biogenfoundation initiatives, and the dedication of our employees. Read more about our work in the community:
-
Biogen
@biogen
We proudly support the @WBCSD Business Manifesto for Climate Recovery. Launched at #cop26, the Manifesto represents the first time the world’s most sustainable businesses have used their voice to outline requirements for #climateaction. Learn more:
-
Biogen
@biogen
Collaboration will be critical to fight #climatechange. Today at @COP26’s ‘Energy Day,’ we’re proud to be one of ten global pharma companies launching #energize, a first-of-its-kind program to increase #renewableenergy across pharmaceutical supply chains. Learn more here:
#cop26 -
Biogen
@biogen
Martin Dubuc, Head of Biogen Digital Health, highlighted the potential opportunities in the exciting space of wearables, computing, virtual reality and machine learning, during our Investor R&D Day. To view Martin’s presentation and others, click here:
-
Biogen
@biogen
Worldwide, 9 in 10 people breathe air that is harmful to their health – disproportionately impacting the most vulnerable among us. Today we join the @WEF #allianceforcleanair Coalition as a founding member committed to #healthequity. Learn about the Coalition and our commitment:
-
Biogen
@biogen
We’ve partnered with the European Alliance of Neuromuscular Disorders Associations to improve communication between physicians, patients, and caregivers about drug development phases and discovery, clinical trial design, and more. Download the brochures here:
-
Biogen
@biogen
Congratulations to @MGHNeurology ‘s @DrNicteMejia, the inaugural recipient of ANA’s Audrey S. Penn Lectureship Award. The MGH Youth Neurology Program is one example of her drive to promote health equity.
#stem | #stemeducation -
Biogen
@biogen
“#climateaction is essential for human and planetary wellbeing.” During #cop26, Alphonse Galdes, EVP of Pharmaceutical Operations & Technology at Biogen, wrote about the urgent need for climate efforts that protect human health. Read more.
#cop26 #health #healthyclimate -
Biogen
@biogen
#ctad21, hosted by @CTADConference, is just around the corner. We look forward to sharing our latest research in #alzheimersdisease, including several late-breakers. Read our news release:
-
Biogen
@biogen
We believe that no other disease area holds as much need or as much promise for medical breakthroughs as #neuroscience. Learn more about our focus and deep scientific expertise in the research and development of medicines:
-
Biogen
@biogen
We remain committed to hiring and cultivating a #diverse and #inclusive team across the globe. We look forward to connecting with potential candidates at this year’s @NSNHQ Conference & Career Fair. Meet with us in Booth 613:
-
Biogen
@biogen
We are grateful for the opportunity to partner with @FNIH_Org on the Accelerating Medicines Partnership® – Bespoke Gene Therapy Consortium, an effort to establish a standardized process for developing #genetherapy in #raredisease. Learn more: fnih.org/news/press-releases/fnih-announces-transformativ…
-
Biogen reposted
AFRO News afro.com
@afronews
Recognizing the racial and ethnic disparities in Alzheimer’s Disease
www.afro.com/recognizing-the-racial-and-ethnic-disparitie…
#alzheimer’s #alzheimer’sDisease #biogen #usagainstalzheimer’s #mybrainguide -
Biogen
@biogen
Honored to receive @LESUSACanada's Deal of Distinction Award with @Denalitx for our collaboration to research and develop therapies to treat #neurodegenerative diseases.
-
Biogen
@biogen
Recognizing the signs of #stroke early is essential. Unfortunately, public awareness of the major signs and symptoms was shown by the CDC to be low among people surveyed (2005) in 13 US states. Help us raise awareness this #worldstrokeday by learning the signs and retweeting:
-
Biogen
@biogen
Science-based targets are crucial to driving #climateaction. We were proud to join the @sciencetargets initiative to set bold science-based targets to help prevent the impacts of climate change #sciencebasedtargets. Learn more:
-
Biogen
@biogen
We collaborated with @MGHNeurology in developing the Youth Neurology Program, which offers hands-on research opportunities to help build a diverse pipeline of future neuroscientists and neurologists. Learn more:
-
Biogen
@biogen
Today is #worldpsoriasisday2021. An estimated 125 million patients worldwide live with this condition. With our Biogen Biosimilar Unit we are proud to support the #psoriasis community on this important awareness day.
-
Biogen
@biogen
We look forward to participating in this year’s @NSNHQ Conference & #careerfair and connecting with top talent to support our work in #neurology. Find more information and register today:
-
Biogen
@biogen
Our pioneering spirit allows us to challenge the status quo and pursue new possibilities. Learn more about our team’s determination to innovate:
-
Biogen
@biogen
We are working with @MITGlobalChange and the @TPPMIT to model how various #climate choices impact #humanhealth. We aim to help policymakers & others make data-driven decisions that prioritize #climateaction that benefits #publichealth. Learn more:
-
Biogen
@biogen
We’ve seen a growing emphasis on the #multiplesclerosis (MS) patient experience at the @mscare meeting this year and will continue to strive to incorporate these insights to better understand this disease as we innovate. Learn more about our work and pipeline:
-
Biogen
@biogen
Ahead of this year’s @COP26, our CEO Michel Vounatsos signed an open letter on behalf of the @wef Alliance of CEO Climate Leaders, encouraging governments and businesses to take decisive steps to address #climatechange. Read the letter here: www.weforum.org/agenda/2021/10/cop26-ceo-climate-alliance…
#cop26 -
Biogen
@biogen
We’re delighted to recognize Nobel laureate & Biogen co-founder Phillip Sharp with a named space in the new @MITMuseum and support Essential MIT, an opening exhibit focused on solving real-world problems such as the #climatecrisis. Learn more:
-
Biogen
@biogen
Thibaud Guymard, General Manager of Digital Measurement Solutions at Biogen Digital Health, explains the different types of digital medicine solutions and their potential applications in helping to improve the lives of individuals with #neurological diseases.
-
Biogen
@biogen
Together with @MIT we are accelerating action on the greatest challenges of our time: #climate, #health and #equity. We are pleased to be the first biotech to join @MITCSConsortium to further our #fossilfuelfree commitment and advance #climateaction. Read more:
-
Biogen
@biogen
“Health education occurs over a lifetime – but like other inequities, the understanding we receive depends more on our circumstances than our needs.” - Dr. Dylan Wint, Director at @ClevelandClinic. Learn more about his perspective on #healthequity in this video:
-
Biogen
@biogen
In a new interview, Alfred Sandrock, Head of Research and Development, discusses how our growing understanding of genetics and the use of biomarkers and measurement tools may provide insights that could revolutionize the field of medicine. Read more:
-
Biogen
@biogen
We are glad to participate in this year's @mscare 2021 Annual Meeting, with 12 posters and 1 presentation showcasing cutting-edge research and clinical innovations for the #multiplesclerosis (MS) community. Learn more:
-
Biogen
@biogen
Through our STAR Program, the Biogen Foundation has committed $10 million to support #stemeducation in Massachusetts. The program has served thousands of students of color, low-income students and English language learners. Learn more: www.biogen.com/en_us/star-initiative.html?cid=osm-twtr-es…
This media couldn't be displayed. See it on the original post. -
Biogen
@biogen
We are hosting a #multiplesclerosis (MS) Product Theater at @mscare 2021 Annual Meeting - the largest North American meeting for healthcare professionals and researchers interested in MS. Attending CMSC? Join us virtually at 6:30pm EST on Tuesday October 26th. Learn more:
-
Biogen
@biogen
Is Europe Ready to Address Alzheimer’s Disease and Brain Health? Join us today to hear more from our great panel of speakers during this @WorldHealthSmt event #whs2021
-
Biogen
@biogen
Dr. Dylan Wint, Director, @ClevelandClinic Lou Ruvo Center for Brain Health, joins us to explore how we can all make active efforts to help improve the #alzheimers care we deliver to underrepresented and underserved patients. Watch the video here:
-
Biogen
@biogen
.@TheLancet has published its anticipated report which tracks the impact of #climatechange on human #health. We recognize the climate crisis is also a public health crisis and we’re committed to accelerating our action to address these urgent and interrelated issues. Learn more:
-
Biogen
@biogen
Dr. Dylan Wint, Director at @ClevelandClinic, discusses the challenges of #healthequity faced by underserved and underrepresented communities. Learn more in this video from our new #alzheimers disease educational series for HCPs, the RoAD Show:
-
Biogen
@biogen
To kick off #massstemweek, we were joined by Kenn Turner, President & CEO @MALifeSciences, who spoke with students at Biotech in Action, a collaboration between Biogen's Community Lab & @LemelsonMIT. Learn how Biogen’s #stem programs have inspired 60K+ students:
@MassStemWeek -
Biogen
@biogen
For more than a decade, Biogen has been committed to gaining a deeper understanding of ALS. We aim to learn more about the important role genetics can play in this devastating disease.
-
Biogen
@biogen
Today, Biogen and @SageBiotech announced plans to submit a new drug application (#nda) to the FDA for our investigational drug for major depressive disorder (#mdd) and postpartum depression (#ppd).
-
Biogen
@biogen
For over a decade, Biogen has been committed to advancing ALS research to provide a deeper understanding of the disease. Learn more about ALS, including genetic ALS:
-
Biogen
@biogen
Today we announced important news for people with SOD1-ALS. Results from a Phase 3 study in SOD1-ALS and an access update are available here:
-
Biogen
@biogen
Today we’re excited to support and participate in the @LupusOrg #walktoendlupusnow. Hear more about how we’re striving to drive change and helping to improve health outcomes through community engagement in our clinical research.
-
Biogen
@biogen
We were honored to receive the Corporate Champion Award at the Trish Vradenburg Gala and are proud to support this @UsAgainstAlz event.
-
Biogen
@biogen
#multiplesclerosis changed Katia’s life, but she chooses to embrace the new and find solidarity in the diverse relationships she has found within the #ms community. #msbeyondwords #ectrims2021 www.youtube.com/watch?v=WibCmJwaAiM
-
Biogen
@biogen
Tomorrow we'll be attending @LupusOrg’s #walktoendlupusnow virtual event where we'll be sharing some of the ways we support the #lupus community. Once you're logged into the Walk app, visit the "Exhibition Hall" and stop by our booth to say hi and learn more:
-
Biogen
@biogen
With our unmatched experience in #multiplesclerosis, we see hope for the MS patient as we advance research initiatives across key patient outcomes. Maha Radhakrishnan, MD, Chief Medical Officer at Biogen provides her insights on this year’s #ectrims2021 presentations.
-
Biogen
@biogen
We see the climate crisis as a health crisis. That’s why we’re proud to commit to a 1.5°C pathway with @ScienceTargets and are calling on companies across the globe to join us. Learn more:
#climateactionday -
Biogen
@biogen
Last year, Donna told us her connections help her to understand that she’s not alone. Watch her #multiplesclerosis story here, now in Punjabi, as we connect with more people across the global #ms community. #msbeyondwords #ectrims2021 www.youtube.com/watch?v=nLTBkN5basc
-
Biogen
@biogen
We’re proud to announce that CEO Michel Vounatsos is a recipient of the Individual Leadership Award at @TheCLC2021. This award recognizes his extraordinary efforts to address the interrelated challenges of #climate and #health. Learn more about this year’s winners:
-
Biogen
@biogen
Smartphone technology may help monitor #multiplesclerosis (MS) measurements between in-clinic appointments. We continue to advance innovative research on digital outcome measurements in #ms. Check out poster P308 on standardizing these digital assessments at #ectrims2021.
-
Biogen
@biogen
We are sharing 38 posters and presentations from across our #multiplesclerosis portfolio at #ectrims2021. Read more:
-
Biogen
@biogen
This #worldsightday and beyond, we strive to raise awareness of global blindness and visual impairment.
Learn more about this important awareness day:
#loveyoureyes -
Biogen
@biogen
Living with #ms presents some challenges for Jacobo, but this doesn’t stop him from doing the things he loves. #msbeyondwords #multiplesclerosis #ectrims2021 www.youtube.com/watch?v=kwwvEQtck2k
-
Biogen
@biogen
#hcps: register and join our #ectrims2021 symposium for discussion on advancing #multiplesclerosis treatments and technologies for the #ms community. For more information:
-
Biogen
@biogen
This #hispanicheritagemonth we join in celebrating the contributions of this vibrant community. Manuel (Manny) Mendoza, one of our SMA Family Access Managers, credits being bilingual with opening doors throughout his career. Learn about our commitment to diversity and inclusion:
-
Biogen
@biogen
We are pleased to present data at the #ectrims2021 virtual conference on #covid19 vaccine antibody response for individuals living with #multiplesclerosis. Read more:
-
Biogen
@biogen
US job seekers, we’re #hiring! Join us Oct. 20th at the @gettinghired Online #career Expo to talk with Biogen recruiters about job opportunities for people with #disabilities.
-
Biogen
@biogen
Today is #worldarthritisday2021. We support the rheumatic and musculoskeletal disease communities, and encourage the estimated 100 million Europeans who have these diseases but are undiagnosed to connect with their physicians to learn more.
-
Biogen
@biogen
-
Biogen
@biogen
Meet Jacobo from Spain. Diagnosed with #multiplesclerosis at 22, he decided that #ms would not be an obstacle in his life. #msbeyondwords
-
Biogen
@biogen
While celebrating Hispanic and Latinx Heritage Month, we want to recognize our Hispanic and Latinx colleagues who bring so much to our team. Learn more about our commitment to #diversity, #equity, and #inclusion. #hispanicheritagemonth
-
Biogen
@biogen
We are proud to sponsor the @UsAgainstAlz 8th Annual Trish Vradenburg Gala, featuring virtual live programming and interactive opportunities to engage with special guests and attendees. Learn more:
-
Biogen
@biogen
HCPs: Join us October 12th for our #eugms2021 symposium on #alzheimers disease: an evolving patient journey. @EuGMSSociety
-
Biogen
@biogen
We are continuously evolving to meet the expectations of our communities and we are proud to have this growth recognized as a @HRC #cei2021 Best Places to Work for #lgbtq Equality. This #pridemonth, we reaffirm our commitment to furthering diversity, equity and inclusion.
-
Post not available here, view on X
Biogen
@biogen
Register now for this keynote from @IAmBiotech to hear from Biogen CEO, Michel Vounatsos, as he shares his thoughts on our #corporateresponsibility efforts including our #sustainability and strategic priorities moving forward, plus his perspective on the future of #biotech.
-
Biogen
@biogen
Our mission is to excite more young people about science and inspire the next generation of #stem leaders. Discover how Dr. Amanda Marvelle is helping shape student futures at our Research Triangle Park #communitylab:
-
Biogen
@biogen
The Biogen Foundation is proud to share the STAR Initiative Year 2 Report. Learn more about our continued support of #stem education equity for students typically underrepresented in #stemcareers:
-
Biogen
@biogen
We are proud to celebrate our colleague Antonella Santuccione Chadha who has been awarded the World Sustainability Award 2020 for outstanding contributions to sex and gender-oriented precision medicine through her work with the Women’s Brain Project.
-
Biogen
@biogen
Today Biogen is proud to announce an update on aducanumab, our investigational drug for early Alzheimer’s disease investors.biogen.com/news-releases/news-release-details/b… #alzheimers




































































































